Peringkat Option Implied Volatility

Papan peringkat ini menampilkan daftar perusahaan dengan Option Implied Volatility tertinggi/terendah.

Catatan Penting: Peringkat ini diperbarui beberapa kali sehari, tetapi seringkali ada jeda waktu antara pembaruan data dasar dan saat peringkat mencerminkan nilai-nilai baru. Pastikan Anda membandingkan nilai aktual di halaman ini dengan nilai di halaman saham untuk memastikan keakuratannya sebelum menarik kesimpulan apa pun dari peringkat.

OptionImpliedVolatility
Volatilitas implisit pada harga saat ini, jangka waktu interpolasi 30 hari.

Terakhir diperbarui: 2025-09-06T00:07:01.409266Z

Peringkat Keamanan Industri Kapitalisasi Pasar (MM) Option Implied Volatility
1 US PYXS / Pyxis Oncology, Inc. Pharmaceutical Preparations 118.76 6.84
2 US ABVC / ABVC BioPharma, Inc. Pharmaceutical Preparations 50.20 6.05
3 US KIDZ / Classover Holdings, Inc. 8.02 6.01
4 US VERU / Veru Inc. Pharmaceutical Preparations 49.66 6.01
5 US WHWK / Whitehawk Therapeutics, Inc. Pharmaceutical Preparations 85.30 5.72
6 US ENTX / Entera Bio Ltd.
Entera Bio Ltd. is a biotechnology company based in Israel, primarily focused on the development of orally delivered large molecule therapeutics for use in areas traditionally addressed by injections. A prominent player in the biopharmaceutical sector, the company utilizes its proprietary drug delivery platform to enhance the oral bioavailability of drugs. Noteworthy projects include the advancement of EB613, an oral human parathyroid hormone targeting osteoporosis, which has demonstrated promising Phase 2 results in improving bone mineral density. Entera's innovative approach aims to transform the administration of biologics, thereby potentially improving compliance and outcomes in conditions requiring chronic treatment. The company's strategic initiatives and scientific progress underscore its commitment to revolutionizing the field of therapeutics with oral delivery technologies. 		Biological Products, Except Diagnostic Substances (Biotech) 80.00 5.50
7 US TLPH / Talphera, Inc.
Talphera, Inc. is an American technology firm specializing in artificial intelligence and machine learning. Based in Silicon Valley, it primarily develops advanced AI algorithms and data analytics solutions aimed at enhancing predictive capabilities in various tech-driven sectors. Key projects include the development of a proprietary AI platform that assists in real-time decision-making processes for financial services and an innovative machine-learning application that enhances automation in manufacturing environments. These initiatives underscore Talphera's commitment to pushing the boundaries of AI technology to drive efficiency and innovation. The company has successfully partnered with major industry players, positioning itself as a crucial contributor to technological advancements in AI applications. 		Pharmaceutical Preparations 10.93 5.26
8 US ATYR / aTyr Pharma, Inc.
aTyr Pharma, Inc. adalah perusahaan bioteknologi Amerika yang berbasis di San Diego, California, yang mengkhususkan diri dalam penemuan dan pengembangan obat-obatan inovatif berdasarkan jalur biologis baru. Fokus utamanya adalah pada terapi yang memanfaatkan potensi tRNA sintetase. Salah satu proyek kuncinya berpusat pada ATYR1923 (efzofitimod), protein fusi dalam pengembangan klinis untuk pengobatan berbagai penyakit paru-paru inflamasi berat, termasuk sarkoidosis paru dan penyakit paru interstisial. aTyr Pharma memanfaatkan pengetahuan eksklusifnya tentang biologi tRNA sintetase untuk menargetkan populasi pasien yang kurang terlayani dengan penyakit serius, memposisikan dirinya secara strategis dalam industri bioteknologi untuk mengatasi kebutuhan medis yang belum terpenuhi secara signifikan. 		Biological Products, Except Diagnostic Substances (Biotech) 521.01 5.16
9 US TXMD / TherapeuticsMD, Inc.
TherapeuticsMD, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor perawatan kesehatan, dengan fokus pada kesehatan wanita. Perusahaan ini berdedikasi untuk mengembangkan dan mengkomersialkan produk yang menargetkan kondisi spesifik yang dialami wanita, terutama yang berkaitan dengan terapi hormon terkait menopause. Produk utama dari TherapeuticsMD meliputi ANNOVERA®, BIJUVA®, dan IMVEXXY®, yang merupakan perawatan inovatif yang dirancang untuk mengatasi kebutuhan dan tantangan hormonal wanita menopause. Produk-produk ini menunjukkan komitmen perusahaan untuk memajukan kualitas perawatan kesehatan bagi wanita melalui terapi yang ditargetkan dan didukung secara ilmiah. Melalui fokus khususnya, TherapeuticsMD terus berupaya untuk memberikan solusi yang berdampak di bidang khusus kesehatan wanita. 		Pharmaceutical Preparations 12.39 4.60
10 US TRDA / Entrada Therapeutics, Inc. Pharmaceutical Preparations 187.70 4.49
11 US PEPG / PepGen Inc. Pharmaceutical Preparations 45.59 4.45
12 US STTK / Shattuck Labs, Inc. Pharmaceutical Preparations 74.73 4.11
13 US SERA / Sera Prognostics, Inc. Medical Laboratories 127.01 3.97
14 US ANVS / Annovis Bio, Inc.
Annovis Bio adalah perusahaan platform obat tahap klinis yang menangani neurodegenerasi, seperti penyakit Alzheimer (AD), penyakit Parkinson (PD), dan penyakit Alzheimer pada Sindrom Down (AD-DS). 		Pharmaceutical Preparations 44.82 3.96
15 US CMBM / Cambium Networks Corporation Radio and Television Broadcasting and Communications Equipment 3.85
16 US DFLI / Dragonfly Energy Holdings Corp. Miscellaneous Electrical Machinery, Equipment, and Supplies 10.40 3.73
17 US CODX / Co-Diagnostics, Inc.
Co-Diagnostics, Inc., based in the United States, operates primarily within the biotechnology sector, focusing on the design, development, and commercialization of cost-effective molecular diagnostics solutions. Leveraging patented CoPrimer™ technology, the company creates diagnostic tests for public health, infectious diseases, and genetic disorders, emphasizing tests for tuberculosis, Zika, COVID-19, and malaria. Co-Diagnostics, Inc. combines rigorous research and development practices to create diagnostic tools that are accurate, scalable, and accessible, aiming to serve global markets, including underdeveloped or remote regions. This strategic focus not only addresses high-demand medical needs but also positions the company to navigate complex regulatory landscapes and rapidly evolving healthcare challenges efficiently. 		Surgical and Medical Instruments and Apparatus 11.21 3.63
18 US CATX / Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc., based in the United States, operates within the biotechnology sector with a primary focus on the development of targeted radiotherapeutics for cancer treatment. At the core of its portfolio is a series of projects aimed at advancing the use of radiolabeled small molecules and antibodies that selectively target and destroy cancer cells while minimizing exposure to healthy tissues. The company emphasizes innovation in the radioisotope drug conjugate space, specifically developing therapies that employ isotopes like Actinium-225 and Lutetium-177. These efforts are driven by the aim to improve treatment outcomes and extend survival rates for patients battling various malignancies, marking Perspective Therapeutics as a key player in the oncological radiotherapy industry. 		Pharmaceutical Preparations 257.32 3.45
19 US ARMP / Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri bioteknologi, dengan fokus pada pengembangan terapi berbasis bakteriofag. Pekerjaan perintis perusahaan ini berpusat pada pemanfaatan terapi fag untuk memerangi infeksi bakteri, khususnya yang resisten terhadap antibiotik tradisional. Salah satu proyek utama mereka mencakup platform eksklusif yang dirancang untuk menghasilkan dan mengoptimalkan bakteriofag tersebut untuk penggunaan terapeutik. Armata Pharmaceuticals berkomitmen untuk mengatasi kesenjangan kritis dalam pengobatan infeksi bakteri di berbagai populasi pasien dan telah aktif berkolaborasi dengan entitas perawatan kesehatan global untuk memperluas dan meningkatkan utilitas terapi fag, yang mencerminkan kontribusi signifikan terhadap pengobatan antibakteri yang inovatif. 		Biological Products, Except Diagnostic Substances (Biotech) 103.17 3.37
20 US ALXO / ALX Oncology Holdings Inc. Pharmaceutical Preparations 65.55 3.33
21 US HOLO / MicroCloud Hologram Inc. Computer Programming, Data Processing, And Other Computer Related Services 64.68 3.27
22 US KZR / Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc., yang berbasis di Amerika Serikat, beroperasi di sektor bioteknologi yang berfokus pada penemuan dan pengembangan pengobatan baru untuk penyakit autoimun dan kanker. Sejak awal berdirinya, perusahaan telah berkomitmen untuk memajukan perawatan kesehatan melalui penelitian ilmiah yang inovatif. Proyek utama mereka melibatkan kandidat obat inovatif, KZR-616, yang dirancang sebagai inhibitor imunoproteasom selektif dengan potensi aplikasi di berbagai penyakit autoimun. Selain itu, Kezar Life Sciences mengeksplorasi pengembangan molekul kecil yang menargetkan jalur sekresi protein untuk berbagai keganasan. Pendekatan strategis mereka menggabungkan sains mutakhir dengan terapi yang ditargetkan untuk mengatasi kebutuhan medis yang belum terpenuhi secara signifikan di kedua area penyakit tersebut. 		Pharmaceutical Preparations 29.97 3.26
23 US APT / Alpha Pro Tech, Ltd.
Alpha Pro Tech, Ltd. adalah perusahaan yang berbasis di Kanada, yang aktif dalam pengembangan, manufaktur, dan pemasaran pakaian pelindung dan produk pengendalian infeksi. Perusahaan beroperasi melalui dua divisi utama: Perlengkapan Bangunan dan Pakaian Pelindung Sekali Pakai. Di sektor Perlengkapan Bangunan, produk-produknya, termasuk lapisan bawah atap sintetis dan pembungkus rumah, melayani industri konstruksi, meningkatkan keamanan dan daya tahan struktur arsitektur. Sementara itu, divisi Pakaian Pelindung Sekali Pakai berfokus pada produksi masker wajah, pelindung wajah, dan penutup medis, yang sangat penting dalam mengendalikan infeksi di lingkungan perawatan kesehatan. Alpha Pro Bed Tech secara signifikan berkontribusi pada keselamatan kesehatan masyarakat, terutama yang disorot selama krisis kesehatan seperti pandemi COVID-19, di mana produk-produknya mengalami peningkatan permintaan. Melalui inisiatif ini, Alpha Pro Tech bertujuan untuk memperluas jangkauan pasarnya dan memperkuat kontribusinya terhadap keselamatan di industri perawatan kesehatan dan konstruksi. 		Orthopedic, Prosthetic, and Surgical Appliances and Supplies 50.88 3.24
24 US TKNO / Alpha Teknova, Inc. In Vitro and In Vivo Diagnostic Substances 233.04 3.20
25 US TLSA / Tiziana Life Sciences Ltd Pharmaceutical Preparations 3.17
26 US CAPT / Captivision Inc. 3.16
27 US CSBR / Champions Oncology, Inc.
Champions Oncology, Inc., based in the United States, operates primarily in the biotechnology industry with a significant focus on developing advanced technology solutions and services in cancer research. Founded in 2007, the company specializes in leveraging its technology platforms to personalize oncology drugs and treatments through predictive models derived from implantable human tumors in mice. These tumorgraft models are pivotal in their translational oncology research, assisting pharmaceutical and biotechnology companies in evaluating preclinical and clinical trials of their cancer therapies, thus accelerating their development. Champions Oncology is actively expanding its research reach and continues to innovate in personalized cancer treatment, contributing advancements to the oncology field. 		Biological Products, Except Diagnostic Substances (Biotech) 94.10 3.09
28 US GNLX / Genelux Corporation Pharmaceutical Preparations 125.79 3.05
29 US OVID / Ovid Therapeutics Inc.
Ovid Therapeutics Inc., yang berbasis di Amerika Serikat, beroperasi di industri biofarmasi dan terutama bergerak dalam pengembangan terapi yang menargetkan gangguan neurologis langka. Rangkaian penelitian perusahaan mencakup beberapa proyek inovatif yang berfokus pada pemenuhan kebutuhan medis yang belum terpenuhi. Proyek utama adalah pengembangan OV101 (gaboxadol), pengobatan yang ditujukan untuk kondisi seperti sindrom Angelman dan sindrom Fragile X, memanfaatkan potensinya untuk memodulasi reseptor GABA di otak. Upaya penting lainnya melibatkan kolaborasi mereka dalam mengembangkan OV329, inhibitor GABA aminotransferase, untuk epilepsi resisten pengobatan. Ovid Therapeutics terus berkolaborasi dengan entitas akademis dan korporat, bertujuan untuk mendorong batas-batas ilmu saraf dan meningkatkan kualitas hidup pasien dengan kondisi neurologis yang melemahkan. 		Pharmaceutical Preparations 87.11 3.00
30 US UONE / Urban One, Inc. Radio Broadcasting Stations 41.66 2.98
31 US AURA / Aura Biosciences, Inc. Biological Products, Except Diagnostic Substances (Biotech) 401.60 2.96
32 US RAPP / Rapport Therapeutics, Inc. 523.38 2.87
33 US LAB / Standard BioTools Inc.
Standard BioTools Inc., based in the United States, operates within the biotechnology sector, focusing primarily on providing innovative tools and technologies that facilitate the analysis of biological systems. The company specializes in developing platforms that integrate tools such as mass cytometry and automated microfluidics, offering comprehensive solutions for protein and nucleic acid analysis. A key aspect of their project portfolio includes the advanced mass cytometry system, designed to enhance cellular analysis at the proteomic level, which has significant implications for research in oncology, immunology, and other fields. Standard BioTools places a strong emphasis on pushing the boundaries of molecular diagnostics, aiming to foster advancements in personalized medicine and clinical decision-making. Through its collaborative approach, the company works to establish strategic partnerships and expand its global market presence, significantly shaping the landscape of biotechnological tools and analytics. 		492.74 2.82
34 US KYTX / Kyverna Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 170.26 2.78
35 US BRFS / BRF S.A. - Depositary Receipt (Common Stock)
BRF S.A., yang berkantor pusat di Brasil, merupakan salah satu raksasa di industri makanan global, yang terutama berfokus pada produksi dan penjualan produk unggas, babi, sapi, dan makanan olahan. Perusahaan ini merupakan eksportir terkemuka, dengan posisi yang menonjol di Timur Tengah, Asia, dan Eropa. BRF telah melakukan proyek-proyek keberlanjutan yang signifikan, berupaya meningkatkan tanggung jawab lingkungan dan efisiensi operasionalnya. Inisiatif penting termasuk investasi dalam efisiensi pakan untuk mengurangi emisi gas rumah kaca dan penerapan praktik pengelolaan sumber daya air di seluruh operasinya. Selain itu, BRF terus mengejar inovasi dalam keamanan dan kualitas pangan, memastikan kepatuhan terhadap standar internasional dan meningkatkan keunggulan kompetitif di pasar makanan yang berkembang pesat. 		Meat Packing Plants 2.76
36 US KRMD / KORU Medical Systems, Inc. Surgical and Medical Instruments and Apparatus 187.05 2.73
37 US WYY / WidePoint Corporation Computer Integrated Systems Design 46.66 2.72
38 US ASST / Asset Entities Inc.
Asset Entities Inc. adalah perusahaan AS yang menyediakan layanan pemasaran media sosial di platform seperti Discord dan TikTok. 		Finance Services 75.03 2.71
39 US SOGP / Sound Group Inc. - Depositary Receipt (Common Stock) 137.16 2.58
40 US LRMR / Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., based in the United States, operates within the biotechnology industry, focusing on the development of novel therapeutics for complex rare diseases. A key project of Larimar is their investigational therapy, CTI-1601, which is being developed as a potential treatment for Friedreich’s ataxia, a rare genetic neuromuscular disorder. This proprietary treatment involves a fusion protein designed to deliver human frataxin, the deficient protein in patients with Friedreich’s ataxia, which is essential for mitochondrial function. Larimar’s strategic approach combines rigorous scientific research with targeted clinical trials, aiming to address significant unmet medical needs in the rare disease space, thereby positioning itself as a pioneer in therapeutic innovation. 		Pharmaceutical Preparations 251.95 2.51
41 US MBX / MBX Biosciences, Inc. 387.99 2.49
42 US TEAD / Teads Holding Co. Computer Programming, Data Processing, And Other Computer Related Services 154.32 2.45
43 US SVRA / Savara Inc.
Savara Inc. adalah perusahaan farmasi khusus yang berbasis di Amerika Serikat, yang terutama bergerak dalam pengembangan dan komersialisasi terapi baru untuk pengobatan penyakit pernapasan langka. Proyek utama Savara adalah Molgradex, formulasi inhalasi dari faktor perangsang koloni granulosit-makrofag manusia rekombinan (GM-CSF) yang ditujukan untuk pengobatan proteinosis alveolar paru autoimun (aPAP). Proyek ini mewakili komitmen Savara untuk memenuhi kebutuhan yang belum terpenuhi dalam populasi pasien khusus dengan menargetkan penyebab mendasar dari kondisi ini daripada hanya mengelola gejala. Pada tahun 2023, perusahaan terus fokus pada pengembangan jalur klinisnya untuk memenuhi misinya dalam mengubah kehidupan pasien dengan penyakit pernapasan serius dan yang mengancam jiwa. 		Pharmaceutical Preparations 782.71 2.44
44 US SOND / Sonder Holdings Inc. Hotels, Rooming Houses, Camps, And Other Lodging Places 20.96 2.38
45 US API / Agora, Inc. - Depositary Receipt (Common Stock)
Agora, Inc. is a technology firm based in Shanghai, China, specializing in real-time communication solutions. The company operates predominantly in the software and IT services industry, providing APIs that facilitate voice, video, and messaging functionality across various applications. Noteworthy among its projects is the development of the Agora Real-Time Engagement Platform, which supports a wide range of industries, including gaming, social media, and education, by enabling interactive, real-time user engagement. Agora's offerings are critical in bridging communication gaps in virtual settings, enhancing user experiences by providing reliable and scalable real-time interaction capabilities across global markets. This strategic focus positions Agora as an integral player in the dynamic digital communication technology landscape. 		Prepackaged Software 310.28 2.36
46 US WKSP / Worksport Ltd. Motor Vehicle Parts and Accessories 18.76 2.36
47 US MLGO / MicroAlgo Inc. Computer Programming Services 2.36
48 US STRO / Sutro Biopharma, Inc.
Sutro Biopharma, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri biofarmasi, berfokus pada desain dan pengembangan terapi onkologi dan bioterapi inovatif. Perusahaan ini memanfaatkan platform sintesis protein bebas sel terintegrasi miliknya, XpressCF, untuk menghasilkan terapi protein baru yang memiliki profil terapeutik yang lebih baik untuk pengobatan kanker. Proyek-proyek utama meliputi berbagai antibodi monoklonal dan konjugat antibodi-obat yang ditujukan untuk terapi kanker yang ditargetkan, seperti STRO-001 dan STRO-002, yang sedang dalam uji klinis yang menargetkan CD74 dan reseptor folat alfa, masing-masing. Komitmen Sutro Biopharma untuk memajukan pilihan pengobatan onkologi dengan presisi mendasari upaya penelitian dan pengembangan yang sedang berlangsung. 		Biological Products, Except Diagnostic Substances (Biotech) 89.38 2.36
49 US APYX / Apyx Medical Corporation
Apyx Medical Corporation, based in the United States, operates primarily in the medical technology industry. The company focuses on advancing its proprietary Helium Plasma Technology, which is utilized in surgical procedures including skin resurfacing, coagulation, and ablation. This technology is marketed under the brand name Renuvion, designed for precise applications with minimal invasiveness. Additionally, Apyx Medical is engaged in the development and distribution of electrosurgical products and tools used across various surgical environments. A key area of their business also includes OEM manufacturing services, where they produce proprietary medical devices for other companies. Apyx Medical’s strategic initiatives and innovations are geared towards enhancing safety, efficiency, and outcomes in the medical and cosmetic surgery sectors. 		Surgical and Medical Instruments and Apparatus 75.21 2.35
50 US DCGO / DocGo Inc. Health Services 155.43 2.35
51 US KPTI / Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. adalah perusahaan biofarmasi yang berbasis di Amerika Serikat, tepatnya berkantor pusat di Newton, Massachusetts. Perusahaan ini beroperasi terutama di industri farmasi, berfokus pada penemuan, pengembangan, dan komersialisasi terapi baru untuk pengobatan kanker dan penyakit utama lainnya. Salah satu proyek utamanya adalah pengembangan Selinexor, senyawa penghambat ekspor nuklir selektif (SINE) oral pertama di kelasnya, yang telah menunjukkan potensi dalam mengobati berbagai jenis kanker. Perusahaan telah berhasil mengembangkan senyawa ini melalui berbagai uji klinis, yang mengarah pada persetujuan FDA untuk aplikasi onkologi tertentu. Karyopharm terus memperluas penelitiannya pada teknologi SINE untuk mengeksplorasi potensi terapeutik di berbagai penyakit. 		Pharmaceutical Preparations 57.50 2.32
52 US MAXN / Maxeon Solar Technologies, Ltd.
Maxeon Solar Technologies, Ltd., yang berkantor pusat di Singapura, beroperasi secara menonjol di industri energi surya. Perusahaan ini terkenal dengan panel surya berteknologi tinggi dan produk fotovoltaik inovatifnya. Sebagai pemimpin global dalam inovasi energi surya, Maxeon Solar Technologies berfokus pada pengembangan dan manufaktur rangkaian panel surya Maxeon dan Performance, yang dikenal karena daya tahan, efisiensi, dan manfaat lingkungannya. Proyek utama yang menunjukkan kemampuan Maxeon meliputi penyediaan panel surya canggih untuk instalasi energi terbarukan skala besar di seluruh dunia, membantu pengurangan jejak karbon yang signifikan di berbagai wilayah. Upaya strategis perusahaan dalam mendorong batas-batas teknologi surya menyoroti komitmennya untuk memajukan infrastruktur energi surya secara global sambil bertujuan untuk keberlanjutan dan keamanan energi. 		Semiconductors and Related Devices 67.48 2.29
53 US BDSX / Biodesix, Inc. Medical Laboratories 63.81 2.28
54 US SEAT / Vivid Seats Inc. Miscellaneous Amusement And Recreation 103.89 2.25
55 US WBX / Wallbox N.V. 2.25
56 US DNTH / Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc., yang berbasis di Amerika Serikat, beroperasi di industri bioteknologi, terutama berfokus pada pengembangan solusi terapeutik inovatif. Perusahaan ini berdedikasi untuk memajukan bidang imunologi, dengan penekanan signifikan pada perancangan dan komersialisasi pengobatan baru yang ditujukan untuk mengatasi penyakit autoimun dan inflamasi. Proyek-proyek utama meliputi pengembangan terapi terarah yang bertujuan untuk memodulasi sistem kekebalan tubuh secara tepat, sehingga menawarkan potensi manfaat dibandingkan pengobatan tradisional dengan efek samping yang lebih sedikit dan efikasi yang lebih baik. Dianthus Therapeutics memanfaatkan penelitian dan teknologi mutakhir untuk membangun rangkaian kandidat obat yang kuat, menempatkannya sebagai pemain tangguh di arena penelitian medis yang berfokus pada solusi perawatan kesehatan transformatif. 		Pharmaceutical Preparations 852.36 2.24
57 US LVWR / LiveWire Group, Inc.
LiveWire Group, Inc., based in the United States, operates primarily in the electric vehicle industry, focusing on the production and distribution of electric motorcycles. As a subsidiary of Harley-Davidson, LiveWire is positioned uniquely to leverage advanced technology and an established brand name within the niche of electric motor sports. Notably, LiveWire has spearheaded initiatives such as the launch of the first electric motorcycle, LiveWire ONE, which emphasizes performance blended with sustainable mobility solutions. The company aims to expand its market share and influence in electric vehicle technology by innovating in design, consumer experience, and performance metrics, reinforcing its footprint in an increasingly eco-conscious market. 		Motorcycles, Bicycles, and Parts 722.74 2.23
58 US CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
Cellectis S.A. is a biopharmaceutical company based in Paris, France. It operates within the biotechnology industry, focusing on developing innovative gene-editing technologies to treat severe diseases. The company's primary projects revolve around utilizing TALEN, a proprietary gene-editing technology, to develop immunotherapies for cancer treatment. 		Biological Products, Except Diagnostic Substances (Biotech) 2.22
59 US RDNW / RideNow Group, Inc.
RumbleOn is an e-commerce company using technology to aggregate and distribute pre-owned automotive and powersport vehicles to and from both consumers and dealers. 		Computer Programming Services 151.38 2.21
60 US CLSD / Clearside Biomedical, Inc.
Clearside Biomedical, Inc., yang berbasis di Amerika Serikat, beroperasi di industri biofarmasi, terutama berfokus pada pengembangan terapi inovatif untuk penyakit mata. Pendekatan inovatif perusahaan ini melibatkan penggunaan SCS Microinjector milik mereka untuk mengirimkan obat langsung ke ruang suprachoroidal, menargetkan penyakit seperti uveitis, oklusi vena retina, dan edema makula diabetik. Proyek-proyek utama termasuk XIPERE, pengobatan untuk edema makula yang terkait dengan uveitis, yang menunjukkan komitmen mereka untuk mengatasi kebutuhan medis yang belum terpenuhi dalam oftalmologi. Fokus strategis pada pemberian terapi yang ditargetkan dan spesifik pada lokasi tertentu merupakan bagian penting dari operasi mereka dan misi keseluruhan untuk meningkatkan hasil pasien dalam bidang kesehatan mata. 		Pharmaceutical Preparations 27.47 2.21
61 US CTKB / Cytek Biosciences, Inc.
Cytek Biosciences, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor bioteknologi, dengan fokus pada peningkatan kemampuan teknologi sitometri aliran. Perusahaan ini terkenal karena karya perintisnya dalam mengembangkan dan memproduksi sistem sitometri aliran spektrum penuh yang memberikan analisis sel biologis beresolusi tinggi, yang secara signifikan membantu penelitian ilmiah dan medis. Proyek-proyek utama meliputi pengembangan produk unggulan mereka, sistem Aurora dan Northern Lights, yang menawarkan solusi inovatif untuk analisis sel terperinci di berbagai aplikasi termasuk imunologi, penelitian penyakit, dan diagnostik klinis. Inovasi berkelanjutan Cytek dalam analisis sitometri parameter tinggi menunjukkan komitmennya untuk meningkatkan eksplorasi seluler dan mendukung kemajuan pengobatan personal. 		Laboratory Analytical Instruments 510.65 2.20
62 US GORO / Gold Resource Corporation
Gold Resource Corporation is a mining company based in the United States, principally engaged in the production and development of gold and silver. The company operates primarily in the Americas, with significant projects including the Aguila Project and the Alta Gracia Project in Mexico. These projects focus on both underground and surface mining, extracting gold, silver, as well as base metals such as copper, lead, and zinc, which are subsequently processed to produce concentrates. Gold Resource Corporation has established a reputation for cost-efficient operations and maintaining high environmental and safety standards, aiming to generate substantial shareholder value through efficient production practices, exploration, and asset acquisition strategies. 		Gold And Silver Mining 102.75 2.19
63 US FBRX / Forte Biosciences, Inc.
Forte Biosciences, Inc., based in the United States, operates within the biotechnology sector, focusing specifically on the development of dermatology therapies. The company pioneers innovative treatments for inflammatory skin diseases, aiming to address unmet medical needs. Key projects include their leading program, FB-401, which is a live biotherapeutic for the treatment of inflammatory skin conditions such as atopic dermatitis. The development of FB-401 reflects Forte Biosciences' commitment to leveraging cutting-edge scientific research to improve patient outcomes in dermatological conditions. The company's strategic initiatives prioritize robust clinical trials and the pursuit of novel therapeutic pathways, aiming to provide groundbreaking solutions in the realm of dermatological healthcare. 		Pharmaceutical Preparations 200.69 2.18
64 US NEON / Neonode Inc. Electronic Components, Not Elsewhere Classified 85.70 2.18
65 US BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
BioLineRx Ltd. is a biopharmaceutical development company based in Israel, primarily engaged in identifying, in-licensing, and then developing promising therapeutic candidates, particularly in the oncology sector. The company focuses on advancing a portfolio of cancer therapy projects, with a notable project including Motixafortide, which targets hematological cancers and solid tumors through stimulation of the immune system and other mechanisms. Additionally, BioLineRx is working on AGI-134, a synthetic alpha-Gal immunotherapy for solid tumors that works by harnessing the body’s immune system to target and attack the treated tumor. These projects exemplify the company's commitment to innovating within the therapeutics space, aiming to address unmet medical needs in critical care areas. 		Pharmaceutical Preparations 2.16
66 US MLTX / MoonLake Immunotherapeutics Pharmaceutical Preparations 3,773.54 2.16
67 US FENC / Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. berbasis di Kanada dan beroperasi terutama di industri bioteknologi, yang berspesialisasi dalam pengembangan terapi yang bertujuan untuk mengobati kanker dan penyakit terkait. Proyek utama Fennec Pharmaceuticals adalah pengembangan PEDMARK™, formulasi natrium tiosulfat yang dirancang untuk mengurangi kejadian kehilangan pendengaran akibat cisplatin pada anak-anak dan orang dewasa yang menerima kemoterapi berbasis platinum. PEDMARK™ telah menunjukkan hasil yang menjanjikan dalam uji klinis, menerima penetapan terapi terobosan dari otoritas pengatur atas potensinya untuk mengatasi efek samping yang signifikan dari pengobatan kanker ini. Fokus strategis perusahaan pada pengembangan pengobatan yang berkontribusi pada perawatan pendukung onkologi menggarisbawahi komitmennya untuk meningkatkan kualitas hidup pasien kanker melalui solusi medis yang inovatif. 		Biological Products, Except Diagnostic Substances (Biotech) 245.95 2.15
68 US HEPS / D-Market Elektronik Hizmetler ve Ticaret A.S. - Depositary Receipt (Common Stock)
D-Market Elektronik Hizmetler ve Ticaret A.S., operating primarily out of Turkey, is an e-commerce company engaged in providing a wide range of products and services via its integrated online retail and marketplace platforms. The company, commonly known as Hepsiburada, operates across various sectors, including electronics, fashion, home and garden, and health and beauty. Key projects under its banner focus on enhancing user experience and digital reach, such as the development of advanced logistics solutions and mobile applications to streamline the shopping process. Hepsiburada is also noted for its initiatives aimed at empowering local vendors by integrating them into the digital economy, thereby broadening their market access. 		Catalog and Mail-Order Houses 881.18 2.15
69 US AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
Autolus Therapeutics plc is a biopharmaceutical company based in the United Kingdom, primarily engaged in the development of cancer immunotherapies. The company specializes in the engineering of CAR-T (Chimeric Antigen Receptor T-cells) therapies that are designed to target and destroy cancer cells in a patient-specific approach. A key focus of Autolus Therapeutics’ research and development portfolio is on treatments for hematological cancers, including various forms of leukemia and lymphoma. Their innovative project, AUTO1, is a notable initiative aimed at improving the safety and efficacy of CAR-T therapies for adult acute lymphoblastic leukemia. Autolus is committed to advancing these therapies through clinical trials, aiming to leverage next-generation programmed T cell therapies for sustainable cancer treatments. 		Biological Products, Except Diagnostic Substances (Biotech) 385.90 2.15
70 US CRD.A / Crawford & Company
Crawford & Company, based in the United States, operates primarily in the global claims management industry. The company provides a comprehensive range of services including claims adjustment, third-party claims management, and risk management solutions, aimed at improving operational efficiency and reducing cost for its clients. Crawford has developed specialized expertise in sectors such [as property and casualty insurance, along with services tailored for the automotive and healthcare industries, among others. Notable projects frequently involve large-scale claims processing following natural disasters, sophisticated risk assessments for international firms, and technological innovation like their Crawford TPA Solutions. Crawford’s operations are global, underscoring its role in facilitating business continuity and recovery in diverse markets. 		Insurance Agents, Brokers, and Service 530.80 2.14
71 US SKYE / Skye Bioscience, Inc. Pharmaceutical Preparations 123.95 2.08
72 US ASRV / AmeriServ Financial, Inc. National Commercial Banks 48.73 2.07
73 US FHTX / Foghorn Therapeutics Inc. Pharmaceutical Preparations 321.71 2.07
74 US QURE / uniQure N.V. Pharmaceutical Preparations 985.39 2.06
75 US NINE / Nine Energy Service, Inc.
Nine Energy Service, Inc., headquartered in the United States, is a prominent player in the oilfield services industry. Specializing in completion solutions, Nine Energy provides essential services such as onshore well completions, wireline, and production solutions for unconventional oil and gas operations. The company has a robust presence in major North American shale basins, where it executes strategic projects including well cementing, completion tools, and fracturing. True to its innovative approach, Nine Energy prioritizes technological advancements and operational efficiency to enhance well performance and client productivity, thereby solidifying its role in driving the economic feasibility and development of energy extraction. These efforts are crucial in maintaining the company’s competitive edge in a dynamic and challenging energy market. 		Oil and Gas Field Services, Not Elsewhere Classified 28.42 2.03
76 US ISPR / Ispire Technology Inc. Cigarettes 175.00 2.02
77 US RCON / Recon Technology, Ltd.
Recon Technology, Ltd. is a Chinese company primarily engaged in the oil and gas industry, providing integrated services and equipment. It specializes in automation and enhanced oil recovery technologies designed to optimize fossil fuel production processes. Utilizing advanced software and hardware, Recon's offerings include automation system service, equipment for oil and gas extraction, and development of production techniques. One of the significant aspects of its operations involves digital oilfield solutions, which enhance decision-making processes through real-time data and analytics. Additionally, the company contributes to environmental protection by implementing technologies aimed at reducing oilfield emissions and increasing energy efficiency. Recon Technology demonstrates a pivotal support role in advancing technical efficiencies within China's robust energy sector. 		Oil and Gas Field Services, Not Elsewhere Classified 2.00
78 US HYPR / Hyperfine, Inc. Electromedical and Electrotherapeutic Apparatus 92.33 1.99
79 US ZNTL / Zentalis Pharmaceuticals, Inc. Pharmaceutical Preparations 126.60 1.98
80 US IMUX / Immunic, Inc.
Immunic, Inc., based in the United States, is a biopharmaceutical company specialized in the development of treatments for chronic inflammatory and autoimmune diseases. The company, established with a focus on novel therapeutics, is actively engaged in advancing its pipeline of selective oral immunology therapies. Among its prominent projects is the development of IMU-838, a next-generation selective immune modulator that targets diseased-activated immune cells while leaving normal cells unharmed. This therapy is being explored in multiple Phase 2 and Phase 3 clinical trials for conditions such as multiple sclerosis, ulcerative colitis, and Crohn's disease. By prioritizing these potent, orally available compounds, Immunic aims to address unmet medical needs in autoimmune and inflammatory diseases. 		Pharmaceutical Preparations 74.26 1.97
81 US TPST / Tempest Therapeutics, Inc. Pharmaceutical Preparations 48.73 1.96
82 US IFRX / InflaRx N.V.
InflaRx N.V., based in Jena, Germany, operates in the biopharmaceutical domain, primarily focusing on the development of innovative therapies for inflammatory diseases by targeting the complement system, a key element of the human immune response. The company's hallmark initiative revolves around its lead product candidate, IFX-1, an anti-C5a antibody, which shows promise across various clinical trials for treating diseases such as hidradenitis suppurativa, ANCA-associated vasculitis, and other inflammatory conditions. Furthermore, InflaRx has expanded its pipeline to explore additional compounds and targets with potential therapeutic applications in inflammatory diseases, thereby solidifying its mission to address unmet medical needs through pioneering complement-related therapeutic interventions. 		Pharmaceutical Preparations 112.46 1.96
83 US WOLF / Wolfspeed, Inc.
Wolfspeed, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri semikonduktor, dengan fokus khusus pada material, komponen, dan perangkat silikon karbida dan galium nitrida. Material canggih ini sangat penting untuk produksi aplikasi daya dan frekuensi radio (RF) berkinerja tinggi dan hemat energi. Proyek-proyek utama Wolfspeed melibatkan peningkatan efisiensi dan kinerja sistem listrik di sektor-sektor seperti otomotif (khususnya kendaraan listrik), telekomunikasi, dan sistem energi terbarukan. Karya inovatif mereka mendukung meningkatnya permintaan akan solusi energi berkelanjutan dan teknologi nirkabel generasi berikutnya, menempatkan mereka sebagai pemain penting dalam upaya global untuk meningkatkan efisiensi energi dan memperluas kemampuan jaringan berkecepatan tinggi. 		Semiconductors and Related Devices 193.76 1.96
84 US WWR / Westwater Resources, Inc. Metal Mining 55.93 1.94
85 US BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
Bicycle Therapeutics plc, headquartered in Cambridge, UK, operates primarily in the biotechnology industry and focuses on developing transformative medicines through its proprietary bicyclic peptide (Bicycle®) technology. This innovative technology platform enables the creation of new classes of therapeutics which possess the affinity and specificity typical of antibodies, coupled with the tissue penetration ability of small molecules, aimed at treating cancer and other debilitating diseases. Key projects include their lead candidates BT1718, a novel Bicycle Toxin Conjugate targeted at tumors expressing Membrane Type 1 Matrix Metalloproteinase, and BT5528, a second-generation Bicycle Toxin Conjugate aimed at the EphA2 receptor, a target associated with poor prognosis cancers. Their approach to drug development pioneers avenues in oncology, specifically using a tumor-targeted immune cell agonists strategy to activate immune responses against cancers. 		Pharmaceutical Preparations 494.47 1.93
86 US CPIX / Cumberland Pharmaceuticals Inc. Pharmaceutical Preparations 49.58 1.93
87 US IMNM / Immunome, Inc. Pharmaceutical Preparations 917.12 1.93
88 US RLMD / Relmada Therapeutics, Inc. Pharmaceutical Preparations 54.15 1.91
89 US CGEM / Cullinan Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 412.63 1.90
90 US RDI / Reading International, Inc.
Reading International, Inc., headquartered in the United States, operates as a diversified company with a primary focus on the development, ownership, and operation of entertainment and real property assets. It functions within two major sectors: cinema exhibition and real estate, including retail, commercial, and live theater assets. The company is notably engaged in the cinema business through its theaters in the United States, Australia, and New Zealand, offering a mix of films alongside enhanced cinema experiences. Key real estate projects include the redevelopment and enhancement of significant properties such as Union Square in New York and Entertainment Quarter in Sydney. These endeavors are aligned with Reading International’s strategy to leverage its cinema assets to promote real estate development, thereby integrating and enhancing value across both operational facets. 		Motion Picture Theaters 53.11 1.90
91 US IMMX / Immix Biopharma, Inc. Pharmaceutical Preparations 61.36 1.90
92 US GTIM / Good Times Restaurants Inc. Restaurants, Dining, and Eating Places 17.01 1.89
93 US MNY / MoneyHero Limited 73.66 1.88
94 US RANI / Rani Therapeutics Holdings, Inc. Pharmaceutical Preparations 19.82 1.87
95 US SGMO / Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc., based in the United States, operates within the biotechnology industry, specializing in genomic medicine. The company focuses on developing and commercializing transformative therapies targeting the underlying causes of genetic diseases. Key projects include gene therapy, cell therapy, and genome editing technologies. Notably, Sangamo has pioneered the application of its proprietary zinc finger nuclease (ZFN) genome editing technology, aiming to develop treatments for hemophilia and other genetic disorders. The firm actively collaborates with leading pharmaceutical companies to advance its research and clinical programs, positioning itself at the forefront of gene-edited cell therapy to potentially deliver curative treatments for severe genetic diseases. 		Biological Products, Except Diagnostic Substances (Biotech) 149.25 1.86
96 US BARK / BARK, Inc. Retail Stores, Not Elsewhere Classified 148.50 1.86
97 US CTNM / Contineum Therapeutics, Inc. 298.73 1.86
98 US UGP / Ultrapar Participações S.A. - Depositary Receipt (Common Stock)
Ultrapar Participações S.A., headquartered in Brazil, is a diversified conglomerate primarily involved in the energy and chemical sectors. The company operates through several subsidiaries, among which are Ipiranga, a major distributor of petroleum products; Ultragaz, a leading distributor of liquefied petroleum gas (LPG); and Oxiteno, a provider of specialty chemicals. These subsidiaries allow Ultrapar to maintain a robust presence in both the domestic and international markets. Noteworthy projects include Ultragaz’s initiatives in expanding LPG distribution across Brazil and Oxiteno’s advancements in sustainable chemical solutions, demonstrating Ultrapar’s strategic commitment to innovation and environmental sustainability within its industry operations. Through these key activities, Ultrapar continues to play a critical role in the energy and petrochemical sectors in Latin America. 		Natural Gas Distribution 1.86
99 US ALEC / Alector, Inc.
Alector, Inc., based in the United States, operates primarily in the biotechnology industry, focusing on the development of therapies that harness the human immune system to combat neurodegeneration. The company's innovative approach involves targeting immune dysregulation in the brain, a key factor in neurological disorders such as Alzheimer's disease and frontotemporal dementia. Alector's pipeline includes several key projects like AL001 and AL101, both designed to enhance progranulin levels, thereby potentially modifying the course of neurodegenerative diseases. These projects are in various stages of clinical development, underlining the company's commitment to addressing some of the most challenging conditions affecting the central nervous system. 		Biological Products, Except Diagnostic Substances (Biotech) 304.65 1.85
100 US ARAY / Accuray Incorporated
Accuray Incorporated, based in the United States, operates primarily in the medical technology industry, specializing in the development, manufacturing, and selling of radiation therapy systems. The company's notable contributions include the CyberKnife and TomoTherapy systems, which are designed to deliver precise radiotherapy and radiosurgery treatments for cancerous and non-cancerous tumors, as well as other specified medical conditions. Accuray's innovative solutions focus on improving the accuracy and efficiency of radiation therapy, aiming to maximize patient outcomes while minimizing side effects associated with treatment. The firm's commitment to continuous innovation and global expansion has established its reputation in the precision radiation oncology field, addressing critical needs in cancer treatment worldwide. 		Surgical and Medical Instruments and Apparatus 160.59 1.85
101 US BCAX / Bicara Therapeutics Inc. 657.40 1.84
102 US EQ / Equillium, Inc.
Equillium, Inc. is a biotechnology firm based in the United States, specifically in La Jolla, California. The company primarily focuses on developing novel products for severe autoimmune and inflammatory disorders. A key project for Equillium is itolizumab, a clinical-stage monoclonal antibody designed to modulate the immune system's activity to treat diseases driven by uncontrolled immune activation. Equillium's strategy revolves around leveraging itolizumab’s mechanism of action across various indications, including acute graft-versus-host disease, lupus nephritis, and uncontrolled asthma. This therapeutic approach positions Equillium to address significant unmet medical needs in the areas of inflammation and immune dysfunction. 		Pharmaceutical Preparations 68.05 1.84
103 US TMQ / Trilogy Metals Inc. Gold And Silver Mining 301.38 1.83
104 US MESA / Mesa Air Group, Inc.
Mesa Air Group, Inc., based in Phoenix, Arizona, USA, operates in the aviation sector primarily as a regional air carrier. It provides feeder flights under contractual agreements with major airlines, including American Airlines and United Airlines, through its notable subsidiaries Mesa Airlines and Freedom Airlines. The company's fleet primarily consists of Bombardier CRJ900 and Embraer E175 aircraft, focusing on short-haul routes. As a key player in American regional aviation, Mesa Air Group aims to enhance operational efficiency and fleet modernization, maintaining a strategic presence in significant U.S. hubs to optimize connectivity and passenger convenience while aligning with the operational and business objectives of its mainline partners. 		Air Transportation, Scheduled 54.00 1.83
105 US BSGM / BioSig Technologies, Inc. Electromedical and Electrotherapeutic Apparatus 135.98 1.82
106 US ANY / Sphere 3D Corp.
Sphere 3D Corp., based in Toronto, Canada, operates primarily within the technology sector, focusing on solutions that enable robust data management and desktop virtualization. The company's key initiatives revolve around empowering businesses through innovative storage and virtualization technologies underpinned by a suite of proprietary software products and hardware appliances. Sphere 3D Corp. has notably concentrated its efforts on developing cloud-compliant data solutions that enhance secure accessibility and data recovery. Its projects often intersect cutting-edge sectors such as blockchain technologies and AI-driven platforms, aiming to provide versatile and scalable solutions tailored to meet the evolving demands of digital infrastructure and data-centric applications. 		Finance Services 18.03 1.82
107 US CASI / CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc., yang berbasis di Amerika Serikat, beroperasi di sektor biofarmasi, yang mengkhususkan diri dalam pengembangan dan komersialisasi terapi dan produk farmasi inovatif. Perusahaan ini terutama berfokus pada pengobatan kanker, menekankan pendekatan strategis yang mencakup akuisisi, pengembangan, dan komersialisasi produk dengan fokus geografis utama di Tiongkok. Di antara proyek-proyek utamanya adalah EVOMELA®, suntikan yang digunakan dalam prosedur transplantasi sel punca autolog untuk pasien multiple myeloma, dan portofolio yang mencakup beberapa kandidat lain dalam berbagai tahap pengembangan yang bertujuan untuk mengobati berbagai penyakit onkologi. CASI Pharmaceuticals berupaya menjembatani pasar farmasi Barat dan Tiongkok, dengan tujuan memanfaatkan strategi regulasi dan komersial untuk mempercepat proses pengembangan dan persetujuan obat di wilayah-wilayah utama ini. 		Biological Products, Except Diagnostic Substances (Biotech) 36.44 1.81
108 US OPAD / Offerpad Solutions Inc. Real Estate Agents and Managers 142.01 1.81
109 US OTLK / Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc., based in the United States, operates in the biopharmaceutical industry focusing on the development of complex monoclonal antibodies for various ophthalmic indications. The company's flagship project involves ONS-5010, commercially known as LYTENAVA™ (bevacizumab-vikg), which is an investigational ophthalmic formulation of bevacizumab currently undergoing clinical trials intended to secure FDA approval for the treatment of wet age-related macular degeneration. This project represents a significant advancement in therapeutic options for ocular diseases, aligning with the industry's move towards more targeted and efficacious treatment regimes. The strategic focus on innovative ophthalmic treatments positions Outlook Therapeutics as a niche player in the competitive biopharmaceutical landscape, underscoring its commitment to addressing critical unmet medical needs in the sector. 		Biological Products, Except Diagnostic Substances (Biotech) 40.74 1.81
110 US AREC / American Resources Corporation Bituminous Coal And Lignite Mining 157.23 1.81
111 US JSPR / Jasper Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 44.28 1.79
112 US IMMP / Immutep Limited - Depositary Receipt (Common Stock)
Immutep Limited is an Australian biotechnology company that specializes in the development of immunotherapy treatments for cancer and autoimmune diseases. Founded in 1987 and headquartered in Sydney, Immutep is at the forefront of advancing immunotherapeutic products that harness the body’s immune system. Its key projects focus on the proprietary LAG-3 (Lymphocyte Activation Gene-3) technology, which has yielded multiple product candidates, including eftilagimod alpha (IMP321), positioned as a potential enhancer of the immune response to various tumors. Additionally, Immutep’s pipeline includes multiple partnerships with major pharmaceutical companies aimed at co-developing and commercializing their immunotherapeutic compounds, demonstrating significant investment in research and potential for growth in oncology and beyond. 		Pharmaceutical Preparations 1.79
113 US CVGI / Commercial Vehicle Group, Inc.
Commercial Vehicle Group, Inc. (CVG), based in the United States, operates predominantly in the automotive and commercial vehicle industries. The company specializes in manufacturing and supplying various products, including electrical systems, seating systems, cabin structures, controls, and other related components. CVG caters primarily to the global commercial vehicle market, serving notable heavy-duty trucks and construction equipment sectors. Key projects and initiatives typically emphasize innovation in vehicle solutions, focusing on improving driver comfort, vehicle performance, and overall safety. The company is actively involved in designing and engineering enhancements for a range of commercial applications, demonstrating a strong commitment to meeting the evolving needs of a global clientele in the commercial vehicle sphere. 		Motor Vehicle Parts and Accessories 58.18 1.79
114 US LTRN / Lantern Pharma Inc. Pharmaceutical Preparations 46.54 1.79
115 US ATNM / Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc., yang berbasis di Amerika Serikat, beroperasi di industri biofarmasi dan berfokus pada pengembangan terapi target untuk kanker dengan kebutuhan yang belum terpenuhi. Proyek utama perusahaan berpusat pada teknologi Antibody Radiation Conjugates (ARC) miliknya, yang secara inovatif menggabungkan kemampuan penargetan antibodi dengan kekuatan pembunuh sel dari radiasi. Sebuah proyek penting adalah Iomab-B, sebuah ARC yang ditujukan untuk pengkondisian transplantasi sumsum tulang, yang saat ini sedang dalam uji klinis Fase 3. Selain itu, Actimab-A, produk ARC unggulan lainnya, menargetkan CD33 pada Leukemia Mieloid Akut (AML) dan sedang dalam uji klinis Fase 1/2. Proyek-proyek ini menunjukkan dedikasi perusahaan untuk memajukan pilihan pengobatan baru untuk indikasi onkologi yang menantang. 		Pharmaceutical Preparations 49.76 1.78
116 US LCUT / Lifetime Brands, Inc. Cutlery, Handtools, And General Hardware 95.84 1.78
117 US NTWK / NetSol Technologies, Inc.
NetSol Technologies, Inc. adalah penyedia solusi perangkat lunak TI dan perusahaan global yang berkantor pusat di Calabasas, California, AS. Berfokus terutama pada industri keuangan dan leasing, NetSol menawarkan berbagai layanan termasuk transformasi digital, konsultasi bisnis, dan pengembangan aplikasi. Aspek kunci dari portofolio proyeknya adalah platform NFS (NetSol Financial Suite) Ascent, yang dirancang untuk menyederhanakan operasi pembiayaan dan leasing aset, meningkatkan efisiensi dan otomatisasi untuk bisnis di seluruh dunia. Platform ini secara khusus mendukung transaksi multi-negara, multi-bahasa, dan multi-mata uang, menjadikannya pilihan serbaguna untuk lembaga keuangan global. Lebih lanjut, NetSol secara konsisten terlibat dalam inovasi teknologi, berfokus pada teknologi generasi berikutnya untuk memenuhi tuntutan industri yang terus berkembang. Penekanan strategis perusahaan pada penelitian dan pengembangan mendukung komitmennya untuk mempertahankan keunggulan kompetitif di bidang fintech. 		Prepackaged Software 48.01 1.77
118 US RVPH / Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals adalah perusahaan farmasi tahap klinis yang mengembangkan terapi untuk mengatasi kebutuhan medis yang belum terpenuhi di bidang sistem saraf pusat, kardiovaskular, metabolik, dan penyakit peradangan. Fokus utama Reviva adalah mengembangkan kandidat produk unggulannya, RP5063 (brilaroxazine), untuk pengobatan skizofrenia, gangguan bipolar, dan gangguan depresi mayor. 		Pharmaceutical Preparations 29.91 1.77
119 US TARA / Protara Therapeutics, Inc.
Protara Therapeutics, Inc., based in the United States, operates within the biotechnology industry, focusing on developing treatments for rare and specialized conditions. The company is engaged in rigorous scientific research to address unmet medical needs, particularly in oncology and rare disease sectors. Its key projects include TARA-002, an investigational therapy for lymphatic malformations, which is a primary focus of its clinical development efforts. Additionally, Protara is actively involved in the development of Intravenous (IV) Choline Chloride, a product designed to treat intestinal failure-associated liver disease (IFALD) in patients receiving parenteral nutrition. Through these projects, Protara aims to deliver novel therapeutics that significantly improve patient outcomes. 		Biological Products, Except Diagnostic Substances (Biotech) 121.53 1.77
120 US NFE / New Fortress Energy Inc.
New Fortress Energy Inc. berbasis di Amerika Serikat dan beroperasi terutama di sektor energi, berfokus pada solusi gas-ke-listrik terintegrasi global. Perusahaan ini mengkhususkan diri dalam pembiayaan, pembangunan, dan pengoperasian infrastruktur dan logistik gas alam untuk memberikan solusi energi terintegrasi dan siap pakai yang bertujuan untuk mengurangi biaya dan dampak lingkungan bagi pelanggan di seluruh dunia. Proyek-proyek utama meliputi pengembangan terminal dan infrastruktur LNG di pasar seperti Jamaika, Puerto Riko, dan Brasil, yang menyoroti pendekatan strategisnya dalam memenuhi kebutuhan energi di wilayah yang kurang terlayani. Dengan memanfaatkan LNG dan memfasilitasi transisi menuju sumber energi yang lebih bersih, New Fortress Energy memainkan peran penting dalam membentuk kembali cara energi diproduksi dan dikonsumsi di daerah berkembang. 		Natural Gas Distribution 673.55 1.77
121 US LUNG / Pulmonx Corporation
Nippon Steel Nisshin Co., Ltd., based in Japan, operates within the primary industry of steel production, distinguished as one of the largest steel producers in the world. Embodying a legacy of innovation and quality, the company focuses on a broad spectrum of steel products including specialty steel, sheets, and pipes. Key projects and initiatives under Nippon Steel Nisshin have traditionally centered around advancing technological integration in steel manufacturing processes, enhancing environment-friendly production methods, and pursuing global competitive edges through strategic alliances and expansions. The company plays a crucial role in driving the infrastructure and automotive sectors, amongst others, by providing high durability and precision-engineered steel products. 		Surgical and Medical Instruments and Apparatus 70.15 1.76
122 US CXAI / CXApp Inc. Prepackaged Software 14.50 1.75
123 US NXDT / NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust, based in the United States, operates within the real estate sector focusing on diversified investment strategies. The trust engages in investing directly or indirectly through property ownership or loans secured by real estate across a variety of sectors such as residential, office, and hospitality. One of its key projects includes investments in multifamily properties and opportunistic real estate endeavors that show potential for high return on investment. The trust’s strategy involves leveraging the extensive real estate expertise of its management team to capitalize on undervalued or underperforming assets, enhancing them through targeted value-add initiatives, and implementing efficient operational strategies to maximize income and asset value. 		Real Estate Investment Trusts 179.25 1.75
124 US TYRA / Tyra Biosciences, Inc. Pharmaceutical Preparations 673.40 1.75
125 US BRLT / Brilliant Earth Group, Inc. Jewelry, Silverware, And Plated Ware 41.15 1.74
126 US AIRJ / AirJoule Technologies Corporation 271.49 1.73
127 US SUIG / SUI Group Holdings Limited Finance Services 37.65 1.73
128 US XNCR / Xencor, Inc. Pharmaceutical Preparations 609.59 1.72
129 US CCCC / C4 Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 193.14 1.72
130 US KLXE / KLX Energy Services Holdings, Inc.
KLX Energy Services Holdings, Inc., yang berkantor pusat di Amerika Serikat, beroperasi terutama di industri jasa perminyakan, menyediakan berbagai solusi dan layanan teknis yang komprehensif untuk sektor eksplorasi minyak dan gas darat. Perusahaan ini mengkhususkan diri dalam menyediakan produk dan layanan yang mendukung seluruh siklus hidup ladang minyak, mulai dari pengeboran dan evaluasi hingga produksi, pemeliharaan, dan peningkatan. Penawaran utama meliputi pengeboran terarah, penempatan sumur, dan solusi penyelesaian canggih, yang memungkinkan efisiensi operasional dan efektivitas biaya bagi klien yang menavigasi pasar minyak dan gas yang kompleks. KLX Energy Services bertujuan untuk memanfaatkan keahlian teknis dan pengetahuan industrinya untuk mendorong kemajuan teknologi dan praktik berkelanjutan di sektor ini. 		Oil and Gas Field Services, Not Elsewhere Classified 33.91 1.71
131 US FATE / Fate Therapeutics, Inc.
Fate Therapeutics, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor biofarmasi, berfokus pada pengembangan imunoterapi seluler terprogram untuk kanker dan gangguan imun. Teknologi perusahaan dibangun di atas pemanfaatan kemampuan biologis sel imun, termasuk sel pembunuh alami (NK) dan sel T, antara lain, dari sel punca pluripoten terinduksi (iPSC). Pendekatan inovatif ini memungkinkan produksi massal pengobatan berbasis sel multipoten yang siap pakai. Fate Therapeutics secara aktif memajukan beragam lini produk imunoterapi seluler, memimpin proyek-proyek yang mencakup beberapa uji klinis yang bertujuan untuk mengatasi keganasan hematologi dan tumor padat. Perusahaan telah menjalin kolaborasi strategis dengan entitas besar untuk meningkatkan berbagi sumber daya dan kemampuan pengembangan di bidang penelitian mutakhirnya. 		Biological Products, Except Diagnostic Substances (Biotech) 114.66 1.70
132 US OPEN / Opendoor Technologies Inc.
Opendoor Technologies Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri real estat, khususnya dalam domain platform digital untuk real estat perumahan. Didirikan pada tahun 2014, perusahaan ini telah merevolusi model real estat tradisional dengan menawarkan pasar online yang memungkinkan pembelian dan penjualan rumah dengan cepat. Platform Opendoor menyederhanakan proses transaksi real estat dengan memberikan penawaran tunai instan kepada penjual, sehingga menghilangkan waktu penutupan yang lama dan ketidakpastian yang khas dalam transaksi real estat konvensional. Perusahaan ini memanfaatkan kombinasi teknologi, analitik data, dan pembelajaran mesin untuk menilai nilai properti secara akurat dan menyederhanakan transaksi real estat, menjadikannya pemain kunci dalam evolusi pasar real estat yang didorong oleh teknologi. 		Real Estate Agents and Managers 4,871.06 1.70
133 US BSBR / Banco Santander (Brasil) S.A. - Depositary Receipt (Common Stock)
Banco Santander (Brasil) S.A., based in Brazil, operates as a subsidiary of the global banking group, Banco Santander, S.A., originating from Spain. Positioned prominently in the financial services sector, the bank engages in various activities, including retail banking, direct banking, commercial banking, and asset management. It catandidates facilities to both individuals and corporate clients extending services such as loans, credit cards, and savings products, alongside investment and insurance solutions. Its significant emphasis on digital innovation led to the development of the Superdigital platform, aimed at broadening financial inclusivity by providing banking services across the digital divide. Banco Santander (Brasil) stands out for its focus on sustainable banking initiatives, integrating financial products with environmental and social responsibility, enhancing its corporate marketability in emerging economies. 		Commercial Banks, Not Elsewhere Classified 40,716.78 1.70
134 US PRPH / ProPhase Labs, Inc. Pharmaceutical Preparations 14.68 1.69
135 US CABA / Cabaletta Bio, Inc. Biological Products, Except Diagnostic Substances (Biotech) 154.55 1.69
136 US BNC / CEA Industries Inc. 16.67 1.69
137 US CAN / Canaan Inc. - Depositary Receipt (Common Stock)
Canaan Inc., headquartered in China, is a prominent player in the technology sector, primarily specialized in the research, development, and sales of integrated circuit final system products, including application-specific integrated circuits (ASIC). These specialized chips are heavily utilized in cryptocurrency mining, with the company being among the pioneers in developing ASICs tailored for blockchain mining operations. Canaan Inc. has solidified its presence by expanding its offerings to include AI chip solutions, further diversifying its technological impact. The company’s most notable endeavors include establishing reliable supply chains for its advanced hardware and venturing into AI-driven applications, which synergistically enhance its core operations in the cryptocurrency mining field. 		Finance Services 351.08 1.68
138 US CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) Pharmaceutical Preparations 2,102.44 1.68
139 US DAIO / Data I/O Corporation Instruments for Measuring and Testing of Electricity and Electrical Signals 30.28 1.67
140 US GYRE / Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc., based in the United States, operates primarily in the biotechnology industry, focusing on developing innovative gene therapies. The company dedicates itself to advancing treatments for various genetic disorders, leveraging cutting-edge technology to enhance both delivery mechanisms and the precision of gene editing. A notable project involves their pioneering work on CRISPR-based therapies, designed to correct genetic defects at the molecular level. As of the last review, Gyre Therapeutics has been actively engaged in preclinical trials, aiming to address unmet medical needs within the genetic disease treatment landscape, thereby positioning itself as a potential leader in the field of genetic medicine. The company's strategic research initiatives and partnerships amplify its potential for significant contributions to gene therapy. 		Pharmaceutical Preparations 702.06 1.67
141 US QVCGA / QVC Group Inc.
Qurate Retail, Inc., headquartered in the United States, operates as a prominent player in the video and online commerce industries. The company harnesses its platforms to offer a wide range of consumer products, from fashion to electronics. By leveraging its proprietary technologies in video commerce across TV networks and online platforms, Qurate Retail, Inc. actively shapes an immersive shopping experience. Its key projects include enhancing digital engagement through advanced data analytics and expanding global reach with localized content, aiming to blend retail, media, and social interaction seamlessly. As of its recent strategy, Qurate Retail, Inc. focuses on maximizing customer value through innovative product curation and personalized shopping experiences, adapting to the rapidly evolving digital retail landscape. 		Catalog and Mail-Order Houses 107.45 1.67
142 US VTGN / Vistagen Therapeutics, Inc. Pharmaceutical Preparations 103.66 1.67
143 US IZEA / IZEA Worldwide, Inc.
IZEA Worldwide, Inc., based in the United States, is a prominent player in the influencer marketing industry. The company provides a comprehensive platform that facilitates the connection between brands and content creators, fostering partnerships that enable impactful social media campaigns. Key projects and services include IZEAx, an influencer marketing platform designed to streamline the process of content creation and distribution, and BrandGraph, which offers analytics and insights into social content performance and industry trends. IZEA Worldwide, Inc. serves a diverse range of clients, from small businesses to large enterprises, helping them harness the power of influencer relationships in the digital marketing space. 		Advertising 60.04 1.66
144 US CERS / Cerus Corporation
Cerus Corporation, based in the United States, operates predominantly in the biotechnology sector, focusing on the development and commercialization of the INTERCEPT Blood System. This innovative system is designed to enhance blood safety by reducing the risk of transfusion-transmitted infections through the inactivation of pathogens present in donated blood. The primary technologies involved target platelets, plasma, and red blood cells, catering to a global need for safe blood supplies for transfusions. Cerus' key projects center around expanding the adoption of the INTERCEPT treatment system across blood centers worldwide, while continuously advancing research to broaden its applicability to more blood components and meet various regulatory standards for transfusion medicine. The company's efforts extend into multiple international markets, emphasizing both technological innovation and strategic partnerships to drive broader utilization and acceptance of their blood safety technologies. 		Surgical and Medical Instruments and Apparatus 253.85 1.66
145 US CAPR / Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc., yang berkantor pusat di Amerika Serikat, beroperasi terutama di sektor bioteknologi. Perusahaan ini berfokus pada pengembangan terapi biologis untuk penyakit dengan kebutuhan medis yang belum terpenuhi, termasuk gangguan langka seperti distrofi otot Duchenne (DMD) dan kondisi lain yang melibatkan kerusakan otot jantung dan rangka. Proyek utama melibatkan kandidat unggulannya, CAP-1002, yang terdiri dari sel-sel yang berasal dari kardiosfer alogenik yang bertujuan untuk memodulasi respons imun tubuh dan memfasilitasi regenerasi otot. Pendekatan inovatif perusahaan ini menyoroti dedikasinya untuk mengatasi tantangan kesehatan penting dengan memanfaatkan potensi terapeutik teknologi sel dan eksosom, yang telah menempatkannya di garis depan pengobatan regeneratif dan pengobatan penyakit terkait otot. 		Pharmaceutical Preparations 309.01 1.66
146 US HBIO / Harvard Bioscience, Inc.
Harvard Bioscience, Inc., based in the United States, operates prominently within the life sciences industry. Specializing in the development, manufacture, and sale of a wide range of specialized products, the company primarily caters to the research needs of scientific and clinical communities. Key products include fluidics systems, apparatus for molecular biology research, and instruments for animal physiology procedures. Harvard Bioscience is known for its strong emphasis on innovation and collaboration in the fields of drug discovery, regenerative medicine, and biotechnology research. It engages in ongoing projects aimed at enhancing the capabilities of its offerings, furthering its reach into global markets, and addressing the dynamic demands of biomedical research infrastructure. 		Laboratory Analytical Instruments 21.37 1.66
147 US UP / Wheels Up Experience Inc. Air Transportation, Nonscheduled 1,492.35 1.66
148 US CDLX / Cardlytics, Inc.
Cardlytics, Inc. adalah perusahaan teknologi berbasis di AS yang terutama beroperasi di industri periklanan digital. Didirikan pada tahun 2008 dan berkantor pusat di Atlanta, Georgia, Cardlytics memanfaatkan platform miliknya sendiri yang terintegrasi dengan lembaga keuangan untuk menawarkan solusi pemasaran yang ditargetkan berdasarkan data pengeluaran pelanggan. Perusahaan ini bermitra dengan bank-bank besar untuk memanfaatkan aliran transaksi yang kaya, menggunakan data ini untuk memberi pemasar kesempatan untuk menyampaikan konten iklan yang relevan langsung kepada konsumen. Proyek-proyek utama berfokus pada transformasi data transaksi menjadi wawasan yang dapat ditindaklanjuti, mempromosikan penawaran melalui jaringan lembaga keuangan, dan meningkatkan efektivitas pemasaran. Secara keseluruhan, Cardlytics bertujuan untuk menjembatani kesenjangan antara pengiklan dan konsumen melalui platform pemasaran berbasis datanya, mendorong keterlibatan konsumen yang lebih personal dan efisien. 		Computer Programming, Data Processing, And Other Computer Related Services 49.81 1.65
149 US IVVD / Invivyd, Inc. Biological Products, Except Diagnostic Substances (Biotech) 135.76 1.64
150 US ALTI / AlTi Global, Inc. Miscellaneous Chemical Products 422.52 1.64
151 US BDTX / Black Diamond Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 166.68 1.63
152 US SGHT / Sight Sciences, Inc. Surgical and Medical Instruments and Apparatus 192.00 1.63
153 US KVHI / KVH Industries, Inc. Radio and Television Broadcasting and Communications Equipment 116.37 1.63
154 US TLRY / Tilray Brands, Inc.
Tilray Brands, Inc. adalah pemimpin global dalam produksi dan distribusi produk ganja dan cannabinoid, termasuk untuk penggunaan medis dan rekreasi. Perusahaan ini berfokus pada inovasi dan perluasan pasar untuk menghadirkan produk berkualitas tinggi dan andal kepada konsumen dan pasien di seluruh dunia. 		Medicinal Chemicals and Botanical Products 1,254.53 1.62
155 US FSP / Franklin Street Properties Corp.
Franklin Street Properties Corp., based in the United States, primarily operates within the real estate sector focusing on investment and asset management. Specializing in office properties, the company strategically invests in urban and suburban locations and is known for its portfolio of commercial spaces designed to meet the high demands of small and medium-sized growth companies. Significant activities involve both direct ownership and partnerships through asset-backed investments, with an emphasis on sustainable and profitable growth. Franklin Street Properties Corp. actively manages these assets by employing a keen strategy on property improvements and aggressive marketing to enhance property values and secure high rental occupancy rates, pivoting efficiently to adapt to changing market conditions. 		Real Estate Investment Trusts 174.72 1.62
156 US OBIO / Orchestra BioMed Holdings, Inc. Surgical and Medical Instruments and Apparatus 107.04 1.62
157 US JBIO / Jade Biosciences, Inc. 253.18 1.62
158 US ALTS / ALT5 Sigma Corporation
JanOne Inc. is a United States-based company engaged primarily in the waste management industry, focusing on specialized sectors such as recycling electronics and disposing of hazardous waste materials in an environmentally responsible manner. In addition to its mainline waste management activities, JanOne has recently undertaken projects in the pharmaceutical sector, targeting the development and distribution of non-addictive painkillers. This strategic diversification is part of their broader objective to combat the ongoing opioid crisis in the U.S. by providing safe and effective treatment alternatives. JanOne's innovative approach in both its core and extended business lines illustrates its commitment to addressing critical environmental and social challenges through sustainable business practices and medical advancements. 		Pharmaceutical Preparations 90.01 1.62
159 US TNYA / Tenaya Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 218.62 1.61
160 US CRBU / Caribou Biosciences, Inc. Biological Products, Except Diagnostic Substances (Biotech) 174.61 1.61
161 US NA / Nano Labs Ltd
Nano Labs Ltd. is a China-based technology company specializing in the development and production of high-performance computing chips and related technology solutions. The company focuses on integrated circuit (IC) design, primarily for use in applications such as blockchain mining, artificial intelligence (AI), and data centers. Nano Labs leverages advanced technology to create energy-efficient chips that support high computing power, catering to the growing demand for digital infrastructure in industries like cryptocurrency mining and cloud computing. 		Semiconductors and Related Devices 113.62 1.60
162 US ENIC / Enel Chile S.A. - Depositary Receipt (Common Stock) Electric Services 255,570.43 1.60
163 US FBIO / Fortress Biotech, Inc.
Fortress Biotech, Inc., based in the United States, operates predominantly within the biopharmaceutical sector, focusing on the development and commercialization of novel pharmaceutical therapies. The company's business model hinges on developing partnerships with the biotechnology industry, leveraging their expertise to establish and support a diverse portfolio of project subsidiaries. Key projects typically involve the innovation of treatment options for rare diseases and hard-to-treat conditions, highlighting Fortress Biotech's commitment to addressing unmet medical needs. Their strategic approach integrates in-licensing, developing, and potentially commercializing cutting-edge therapeutic products, often navigating through the complex regulatory landscapes that characterize the pharmaceutical industry. 		Pharmaceutical Preparations 110.09 1.60
164 US LASE / Laser Photonics Corporation Miscellaneous Electrical Machinery, Equipment, and Supplies 29.12 1.60
165 US MBOT / Microbot Medical Inc.
Microbot Medical Inc., yang berkantor pusat di Amerika Serikat, beroperasi di industri biomedis, khususnya berfokus pada desain dan pengembangan teknologi medis mikro-robotik. Perusahaan ini berdedikasi untuk memajukan bidang bedah mikro dengan menciptakan dan menerapkan sistem robotik yang memfasilitasi intervensi bedah yang sangat presisi. Proyek utama yang mencontohkan inisiatif mereka adalah pengembangan Self-Cleaning Shunt (SCS) untuk pengobatan hidrosefalus dan Normal Pressure Hydrocephalus (NPH), yang bertujuan untuk mencegah oklusi shunt, komplikasi umum pada kondisi tersebut. Inovasi penting lainnya adalah Sistem Robotik LIBERTY mereka, yang dirancang untuk memberikan ahli bedah endovaskular presisi dan kontrol yang lebih besar selama intervensi, berupaya mengurangi waktu prosedur dan meningkatkan hasil klinis pada prosedur perifer, kardiovaskular, dan neurovaskular. Proyek-proyek ini menunjukkan misi inti Microbot Medical Inc. untuk merevolusi bedah minimal invasif melalui solusi robotik yang inovatif. 		Surgical and Medical Instruments and Apparatus 139.41 1.60
166 US OMEX / Odyssey Marine Exploration, Inc.
Odyssey Marine Exploration, Inc. adalah perusahaan eksplorasi laut dalam yang berbasis di Amerika Serikat yang mengkhususkan diri dalam penemuan, pengembangan, dan ekstraksi mineral laut dalam. Perusahaan ini merupakan pelopor di bidang eksplorasi mineral dasar laut dan terlibat dalam berbagai proyek di seluruh dunia, dengan fokus kuat pada metode yang bertanggung jawab terhadap lingkungan. Proyek-proyek utama meliputi eksplorasi dan potensi ekstraksi deposit fosfat di lepas pantai Meksiko dan pengamanan hak mineral untuk deposit nodul polimetalik di Pasifik Selatan. Upaya Odyssey bertujuan untuk memenuhi meningkatnya permintaan global akan mineral-mineral penting sambil mempertahankan praktik-praktik berkelanjutan yang berkontribusi pada pelestarian lingkungan laut. 		Water Transportation 56.36 1.59
167 US BNTC / Benitec Biopharma Inc.
Benitec Biopharma Inc. is a biotechnology firm based in the United States, specifically focused within the healthcare sector. The company is pioneering in the development of genetic medicines, utilizing its proprietary gene-silencing technology, ddRNAi (DNA-directed RNA interference), to create therapies that target and potentially silence disease-causing genes. Benitec's pipeline primarily addresses conditions for which conventional treatments are inadequate. Noteworthy projects include therapeutics aimed at chronic and inherited diseases, such as oculopharyngeal muscular dystrophy (OPMD) and chronic hepatitis B. These innovative gene therapy projects position Benitec Biopharma as a key player in the field of genetic medicine, striving to offer novel solutions to complex medical challenges. 		Pharmaceutical Preparations 353.69 1.59
168 US IRWD / Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc., yang berbasis di Amerika Serikat, beroperasi di sektor perawatan kesehatan, khususnya berfokus pada pengembangan dan komersialisasi obat-obatan yang menargetkan penyakit saluran pencernaan. Proyek penting yang dilakukan oleh Ironwood adalah pengembangan dan pemasaran Linzess, obat resep terkemuka yang dirancang untuk pengobatan sindrom iritasi usus besar dengan konstipasi (IBS-C) dan konstipasi idiopatik kronis (CIC). Portofolio perusahaan juga mencakup proyek-proyek inovatif yang dirancang untuk memenuhi kebutuhan yang belum terpenuhi di bidang saluran pencernaan. Ironwood Pharmaceuticals memanfaatkan kombinasi penelitian dan pengembangan internal serta kemitraan strategis, memposisikan dirinya sebagai pemain terkemuka di industri farmasi khusus, yang terus berupaya meningkatkan hasil pengobatan pasien melalui solusi terapeutik baru. 		Pharmaceutical Preparations 187.61 1.59
169 US FKWL / Franklin Wireless Corp. Telephone and Telegraph Apparatus 47.96 1.58
170 US OMER / Omeros Corporation
Omeros Corporation, yang berbasis di Amerika Serikat, adalah perusahaan biofarmasi yang dikenal karena pendekatan inovatifnya dalam pengembangan dan komersialisasi obat yang menargetkan peradangan, koagulopati, dan gangguan sistem saraf pusat. Proyek-proyek utama meliputi OMS721, penghambat jalur lektin, yang digunakan untuk pengobatan sindrom hemolitik-uremik atipikal (aHUS) dan nefropati IgA. Omeros juga telah menjadi berita utama dengan produk Omidria-nya, yaitu midriatik dan anti-inflamasi yang digunakan selama operasi katarak atau penggantian lensa intraokular, yang meningkatkan hasil operasi dengan mencegah penyempitan pupil dan mengurangi nyeri pasca operasi. Fokus strategis perusahaan pada agen terapeutik baru yang mengatasi kebutuhan medis yang belum terpenuhi menandai jejak signifikan perusahaan di industri perawatan kesehatan. 		Pharmaceutical Preparations 249.99 1.57
171 US FLUX / Flux Power Holdings, Inc. Miscellaneous Electrical Machinery, Equipment, and Supplies 24.82 1.56
172 US PLRX / Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc., based in the United States, operates within the biotechnology industry, focusing on developing therapies for fibrotic diseases—a condition characterized by excessive tissue scarring which impairs normal functioning. The company's innovative approach primarily targets the biology of fibrosis, working to halt and potentially reverse the progression of tissue scarring. Key projects include advanced clinical programs like PLN-74809, which is being investigated as a treatment for idiopathic pulmonary fibrosis and primary sclerosing cholangitis, both of which are chronic disorders marked by progressive scarring. Their research pipeline also explores potential treatments for other fibrotic diseases, underscoring Pliant's dedication to addressing significant unmet medical needs through targeted therapeutic development. 		Pharmaceutical Preparations 114.18 1.56
173 US HUSA / Houston American Energy Corp.
Houston American Energy Corp., based in the United States, is a significant player in the energy sector, primarily engaged in the exploration, development, and production of natural resources, specifically oil and natural gas. The company focuses its operations mainly in the Texas and Louisiana regions, capitalizing on the prolific resource plays in these areas. A key project that underscores its strategic initiatives is its involvement in the development of assets in the Permian Basin, one of the most productive oil and gas regions in the U.S. This project, among others, highlights Houston American Energy Corp.'s commitment to leveraging advanced extraction technologies and strategic partnerships to optimize resource development and ensure sustainable growth in its sector. 		Crude Petroleum and Natural Gas 14.06 1.56
174 US FNGR / FingerMotion, Inc. Prepackaged Software 88.52 1.55
175 US ADCT / ADC Therapeutics SA Pharmaceutical Preparations 399.37 1.55
176 US CVU / CPI Aerostructures, Inc. Aircraft Parts and Auxiliary Equipment, Not Elsewhere Classified 31.54 1.55
177 US CUE / Cue Biopharma, Inc.
Cue Biopharma, Inc., based in the United States, operates within the biotechnology sector, focusing primarily on developing innovative immunotherapies. The company's proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without the toxicities associated with conventional treatments. Key projects include therapies targeting various cancers and autoimmune diseases. A noteworthy development stream within its oncology segment includes CUE-101, a fusion protein intended to enhance the immune system's ability to target and eliminate cancer cells expressing the HPV16 E7 protein, currently in clinical trial stages. The firm’s approach integrates strategic partnerships and advanced biotechnological tactics to craft therapies that are both effective and sustainable. 		Pharmaceutical Preparations 59.64 1.54
178 US DH / Definitive Healthcare Corp. Prepackaged Software 420.04 1.54
179 US UAMY / United States Antimony Corporation Primary Smelting And Refining Of Nonferrous 537.60 1.54
180 US QRHC / Quest Resource Holding Corporation
Quest Resource Holding Corporation, based in the United States, primarily operates in the waste management and recycling sector. The company provides solutions aimed at promoting environmental responsibility and sustainability through the management of waste streams and recycling processes. Quest Resource Holding Corporation serves a diverse client base that spans various industries including automotive, grocery, and construction, offering tailored services that encompass the recycling of materials like food waste, glass, and metals. Over the years, the company has been pivotal in developing innovative projects aimed at reducing landfill use and enhancing resource efficiency, making significant strides in advancing recycling technologies and sustainable practices in waste management. 		Refuse Systems 37.07 1.54
181 US KNDI / Kandi Technologies Group, Inc.
Kandi Technologies Group, Inc., based in China, operates primarily in the automotive and battery solutions industries. The company specializes in the production of electric vehicles (EVs) and EV components, distinguishing itself within the market through significant investments in innovative technologies for eco-friendly transportation. Key projects include manufacturing a range of electric cars and off-road vehicles, and developing advanced battery swapping systems. Kandi is also involved in international export, capitalizing on growing global demand for sustainable transportation solutions. The company's ongoing ventures intend to leverage technological expertise to expand its footprint in the electric mobility sector, underpinning its strategy to contribute to a reduced carbon footprint worldwide. 		Motor Vehicles and Passenger Car Bodies 118.73 1.53
182 US NOTE / FiscalNote Holdings, Inc.
FiscalNote Holdings, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor teknologi hukum, menyediakan platform yang menawarkan data hukum dan regulasi secara real-time, bertujuan untuk mengubah cara organisasi global mengelola risiko dan masalah kepatuhan. Perusahaan telah mengembangkan serangkaian layanan perangkat lunak, yang mencakup alat untuk memantau perkembangan legislatif dan regulasi, manajemen pemangku kepentingan, dan manajemen isu, yang dirancang untuk meningkatkan kemampuan pengambilan keputusan lembaga korporasi dan pemerintah dengan memanfaatkan teknologi kecerdasan buatan dan pembelajaran mesin. Penawaran FiscalNote mendukung berbagai entitas dalam menavigasi lingkungan pembuatan kebijakan yang kompleks dan dinamis secara efisien, yang menunjukkan komitmennya untuk mengintegrasikan teknologi mutakhir dengan solusi hukum dan regulasi. 		Business Services, Not Elsewhere Classified 55.75 1.53
183 US ACTG / Acacia Research Corporation
Acacia Research Corporation, based in the United States, primarily operates within the patent licensing sector. As a facilitator of patent monetization, the company focuses on acquiring, developing, and licensing patented technologies. Acacia's model centers on partnering with patent owners, such as inventors and universities, to enforce and license their patents against entities that infringe upon them. This approach effectively assists patent owners in realizing financial gains from their intellectual property. The corporation's key projects often involve strategic litigation processes to defend patent rights, coupled with negotiations to secure licensing agreements that generate revenue for both Acacia and the patent holders they represent. These initiatives are crucial in maximizing the financial potential of intellectual assets in various technological fields. 		Patent Owners and Lessors 318.75 1.53
184 US GETY / Getty Images Holdings, Inc.
Getty Images, Inc. is a US-based company that primarily operates as a supplier of stock images, editorial photography, video, and music for businesses and consumers. Their content offerings range from contemporary creative imagery to news, sports, entertainment, and archival content. 		Business Services, Not Elsewhere Classified 775.70 1.53
185 US TRVG / trivago N.V. - Depositary Receipt (Common Stock) Computer Processing and Data Preparation and Processing Services 238.15 1.52
186 US COOK / Traeger, Inc. Household Appliances 199.73 1.52
187 US SOC / Sable Offshore Corp. 2,268.20 1.52
188 US TNXP / Tonix Pharmaceuticals Holding Corp. Pharmaceutical Preparations 200.35 1.51
189 US BRCC / BRC Inc.
BRC memproduksi dan menjual produk kopi bertema militer dan senjata api dengan merek "Black Rifle Coffee". 		Beverages 124.07 1.51
190 US CRWS / Crown Crafts, Inc. Broadwoven Fabric Mills, Cotton 32.22 1.51
191 US CLGN / CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd., based in Israel, operates within the biotechnology sector, primarily focusing on regenerative and aesthetic medicine. The company leverages its proprietary plant-based recombinant human collagen (rhCollagen) technology for developing tissue repair products. It's known for innovative projects such as BioInks for 3D printing of tissues and organs, and Vergenix™, a line comprising wound healing and orthobiologics solutions. CollPlant's strategic collaborations with international entities aim to advance their penetration in global markets, emphasizing both the therapeutic and commercial potential of its unique technology platforms. This stride in biotechnology highlights their pioneering work in synthetic biology and tissue engineering, positioning them at the forefront of biotechnological innovations in healthcare. 		Orthopedic, Prosthetic, and Surgical Appliances and Supplies 34.59 1.50
192 US TONX / Verb Technology Company, Inc. Personal Services 15.24 1.50
193 US ORKA / Oruka Therapeutics, Inc. 613.07 1.50
194 US ELTX / Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc., based in the United States, operates within the biotechnology industry, focusing primarily on developing immunotherapies for cancer treatment. The company leverages its proprietary Amphiphile technology to enhance the immune system's response against cancerous cells. A key project includes their lead product candidate, ELI-002, an investigational therapeutic vaccine targeting KRAS-driven cancers, which are prevalent and typically aggressive. This vaccine aims to stimulate robust immune responses against multiple KRAS mutations simultaneously, addressing a significant unmet need in oncology. Elicio's innovative approach in immuno-oncology underscores its commitment to advancing cancer treatments through targeted therapies and vaccine development. 		Pharmaceutical Preparations 189.14 1.49
195 US LPSN / LivePerson, Inc.
LivePerson, Inc., headquartered in the United States, operates primarily in the technology sector focusing on artificial intelligence and mobile messaging solutions. The company revolutionizes how businesses engage with customers through its proprietary platforms that facilitate real-time conversations via text and messaging services. A key suite of its offerings includes conversational AI, automation, and analytics tools that empower businesses to deliver enhanced customer service and increase engagement. LivePerson’s notable projects include implementing advanced chatbot solutions that integrate with major messaging services like WhatsApp and Facebook Messenger, making it instrumental in transforming customer communication dynamics across various industries, including retail, telecommunications, and finance. Through its innovative approaches, LivePerson is pivotal in helping businesses optimize customer interactions and operational efficiencies. 		Prepackaged Software 87.46 1.49
196 US NRXP / NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., headquartered in the United States, operates prominently within the pharmaceutical industry. The company is dedicated to pioneering novel therapies, focusing on mental health disorders and inflammatory diseases. A pivotal project undertaken by NRx Pharmaceuticals is the development of Cyclurad, a treatment designed for suicidal bipolar depression, which is an innovation underpinned by intellectual property and strategic collaborations with academic and medical institutions. Another significant initiative focuses on addressing critical care therapies for lung injury and cytokine storm syndrome related to COVID-19, demonstrating the company's commitment to responding to urgent global health crises. NRx Pharmaceuticals continues to evolve its research and clinical trials to meet complex healthcare challenges, leveraging cutting-edge science and strategic partnerships. 		Pharmaceutical Preparations 52.98 1.48
197 US CAAS / China Automotive Systems, Inc.
China Automotive Systems, Inc. is a prominent automotive company based in China, primarily engaged in the production and sale of automotive parts and systems, including power steering systems and other related components. Established in 2003, the company has grown substantially, serving major automotive manufacturers in China as well as international markets. Key projects typically involve the development and integration of advanced steering systems designed to enhance vehicle performance and safety. With a focus on innovation and quality, China Automotive Systems continues to expand its technology and production capabilities to meet the evolving demands of the automotive industry, maintaining a competitive edge within both domestic and global markets. 		Motor Vehicle Parts and Accessories 132.75 1.47
198 US LDI / loanDepot, Inc.
LoanDepot, Inc. is a United States-based company primarily operating within the nonbank consumer lending industry. Founded in 2010, it has established itself as a significant player in the mortgage and non-mortgage loan sectors, catering primarily to residential markets. The company is headquartered in Foothill Ranch, California, and has embarked on key projects focusing on leveraging technology to streamline the mortgage process. Utilizing a digital-first approach, LoanDepot successfully integrates web-based tools and data analytics to enhance customer experiences and operational efficiencies. Its services encompass mortgage lending, refinancing, and personal and home equity loans, making substantial strides in digital innovations to improve access to financial services in the housing market. 		Finance Services 600.97 1.47
199 US TORO / Toro Corp.
Toro Corp. is an energy transportation services company with a fleet of tanker vessels that carry crude oil and petroleum products worldwide. 		Deep Sea Foreign Transportation of Freight 47.84 1.46
200 US NOTV / Inotiv, Inc.
Inotiv, Inc., yang berbasis di Amerika Serikat, beroperasi di sektor biofarmasi dan perawatan kesehatan, terutama berfokus pada penyediaan layanan penemuan dan pengembangan obat. Penawaran utama perusahaan meliputi penelitian obat nonklinis dan analitik, layanan pengembangan, dan konsultasi regulasi, yang melayani klien di industri farmasi, bioteknologi, dan alat kesehatan. Inotiv telah aktif terlibat dalam perluasan kemampuan layanannya melalui akuisisi strategis, seperti pembelian Envigo RMS LLC, yang secara signifikan meningkatkan kapasitasnya dalam penelitian toksikologi dan layanan preklinis lainnya. Strategi ekspansi ini meningkatkan kemampuan Inotiv untuk mendukung kliennya dari tahap penemuan awal hingga pengembangan preklinis, yang menggarisbawahi perannya sebagai penyedia komprehensif di bidang ilmu hayati. 		Commercial Physical and Biological Research 56.34 1.46
201 US CRCA / Proshares Trust - Proshares Ultra Crcl Etf 1.46
202 US QTRX / Quanterix Corporation Laboratory Analytical Instruments 176.48 1.46
203 US RGC / Regencell Bioscience Holdings Limited Medicinal Chemicals and Botanical Products 1.46
204 US ENTA / Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc., yang berkantor pusat di Amerika Serikat, terutama berfokus pada penelitian dan pengembangan obat molekul kecil untuk pengobatan infeksi virus dan penyakit hati. Beroperasi di sektor bioteknologi, Enanta telah memfokuskan upayanya pada area terapi utama, terutama virus hepatitis C (HCV) di mana mereka berkolaborasi dengan Abbott Laboratories, dan virus sinsitial pernapasan (RSV), serta penyakit hati lainnya seperti steatohepatitis non-alkohol (NASH). Perusahaan memanfaatkan keahliannya dalam penemuan obat berbasis kimia untuk mengembangkan pengobatan inovatif yang mengatasi kebutuhan medis yang belum terpenuhi secara signifikan. Sebagai bagian dari inisiatif strategisnya, Enanta Pharmaceuticals terus meningkatkan platform miliknya untuk memperluas jalur pengembangan obatnya dan memajukan upaya penelitiannya di seluruh area inti ini. 		Pharmaceutical Preparations 188.87 1.46
205 US TRON / Tron Inc. Blank Check 73.91 1.45
206 US TTGT / TechTarget, Inc. 403.20 1.45
207 US IOVA / Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri bioteknologi, memfokuskan upayanya pada pengembangan imunoterapi kanker baru yang inovatif. Perusahaan ini secara khusus berinvestasi dalam pengembangan produk limfosit infiltrasi tumor (TIL) untuk pengobatan pasien dengan kondisi kanker berat. Proyek unggulan Iovance meliputi lifileucel untuk melanoma metastatik dan LN-145 untuk kanker serviks dan kepala dan leher. Terapi investigasi ini dirancang untuk meningkatkan aktivitas anti-tumor sel T yang berasal dari pasien dengan memperbanyak dan memasukkannya kembali ke dalam pasien, suatu metode yang berpotensi menawarkan kemajuan signifikan dalam pengobatan kanker yang dipersonalisasi. Dedikasi perusahaan untuk mengubah lanskap pengobatan untuk kanker resisten atau rekuren menempatkannya di garis depan inovasi di bidangnya. 		Biological Products, Except Diagnostic Substances (Biotech) 853.09 1.45
208 US MMLP / Martin Midstream Partners L.P. - Limited Partnership Petroleum Bulk stations and Terminals 123.41 1.45
209 US YSG / Yatsen Holding Limited - Depositary Receipt (Common Stock) Perfumes, Cosmetics, and Other Toilet Preparations 883.11 1.45
210 US SRL / Scully Royalty Ltd.
Scully Royalty Ltd. is a diversified merchant bank headquartered in Bermuda, primarily engaged in iron ore production and merchant banking activities. The company operates through various segments, with a significant focus on the natural resources sector, where it benefits substantially from its iron ore royalty interests. A key aspect of Scully Royalty's operations is the management of its royalty income derived from the Scully Mine, located in Canada, which underpins its fiscal foundation. Additionally, the company's merchant banking division strategically invests in a variety of financial assets, emphasizing a balanced approach to asset management that aligns closely with medium to long-term investment horizons. This divisional structure allows Scully Royalty to diversify risks while capitalizing on opportunities across different sectors and regions. 		Mineral Royalty Traders 1.45
211 US SES / SES AI Corporation Miscellaneous Products Of Petroleum And Coal 395.33 1.45
212 US CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock) Pharmaceutical Preparations 95.04 1.44
213 US ARCT / Arcturus Therapeutics Holdings Inc. Pharmaceutical Preparations 485.68 1.44
214 US SOPH / SOPHiA GENETICS SA
SOPHiA GENETICS SA, based in Switzerland, operates primarily in the biotechnology sector, specializing in data-driven medicine and clinical genomics. The company leverages its AI-powered platform, SOPHiA, to analyze medical data and enhance the diagnostic accuracy for healthcare providers, thus enabling more targeted treatments in oncology, hereditary cancer, metabolism, pediatrics, and cardiology. A key project involves partnerships with hospitals and research institutions to improve cancer diagnostics and treatment strategies through genomic and radiomic analysis. By integrating deep learning into DNA sequencing, SOPHiA GENETICS aids in interpreting complex genetic data, promoting advancements in personalized medicine and optimizing clinical trials. With its focus on innovation in genomics, the company is central to transforming data into actionable insights in healthcare. 		Computer Processing and Data Preparation and Processing Services 219.63 1.44
215 US AIRG / Airgain, Inc.
Airgain, Inc., headquartered in San Diego, California, USA, operates primarily in the technology sector, focusing on the design, development, and engineering of advanced wireless communications solutions. The company specializes in antenna products, including embedded, external, and carrier-class antennas. A key provider for residential wireless local area networking, Airgain's products are instrumental in automotive, enterprise, and industrial markets. Their innovations support a range of applications from global consumer electronics to enterprise and industrial solutions. Furthermore, Airgain has strategically expanded its project portfolio by venturing into Internet of Things (IoT) products and services, underpinning the critical role of high-performance wireless connectivity in driving modern technological advancements. Their expertise in integrating antenna solutions with IoT and mobile technology facilitates robust, high-efficiency communications platforms crucial for today’s digital economy. 		Radio and Television Broadcasting and Communications Equipment 51.78 1.44
216 US BCAB / BioAtla, Inc. Biological Products, Except Diagnostic Substances (Biotech) 31.50 1.44
217 US RCEL / AVITA Medical, Inc.
AVITA Medical, Inc., yang berbasis di Valencia, California, AS, beroperasi di industri bioteknologi, terutama berfokus pada pengobatan regeneratif dan perbaikan kulit. Perusahaan ini terkenal dengan platform teknologi miliknya, RECELL, yang memfasilitasi pembuatan sel kulit autologus dengan cepat untuk mengobati berbagai masalah kulit, termasuk luka bakar, luka kronis, dan ketidaksempurnaan estetika. Proyek-proyek utama AVITA berputar di sekitar perluasan aplikasi terapeutik sistem RECELL dan penyederhanaan protokol perawatan untuk perawatan luka bakar, yang memiliki implikasi penting untuk secara signifikan mengurangi masa inap di rumah sakit dan meningkatkan hasil pemulihan pasien. Perusahaan secara strategis berfokus pada penelitian klinis dan kolaborasi untuk meningkatkan dan memvalidasi penawaran produk regeneratifnya dalam skala global. 		Surgical and Medical Instruments and Apparatus 113.91 1.44
218 US ALLO / Allogene Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 253.15 1.44
219 US SMSI / Smith Micro Software, Inc.
Smith Micro Software, Inc., based in the United States, operates within the software industry, specializing in the development and marketing of telecommunications and graphics software. The company has made significant strides in the wireless communications sector, and offers innovative solutions designed to enhance device and network security, boost connectivity, and improve user experience across various digital platforms. Among its prominent projects are the SafePath® family solutions, which provide family location and parental controls, CommSuite® that manages voice messages and Visual Voicemail, and ViewSpot®, a retail display management platform. Smith Micro Software also has a storied history in graphic design through products like Moho®, a tool for creating 2D animations. This portfolio underscores the company’s commitment to utilizing technology to create integrated user environments across multiple digital touchpoints. 		Prepackaged Software 14.34 1.43
220 US AMBR / Amber International Holding Limited - Depositary Receipt (Common Stock) Prepackaged Software 267.11 1.43
221 US CRML / Critical Metals Corp. 1.43
222 US DSGN / Design Therapeutics, Inc.
Design Therapeutics adalah perusahaan bioteknologi yang mengembangkan kelas terapi baru berdasarkan platform molekul kecil kimera penarget gen (GeneTAC™). Program unggulan perusahaan ini berfokus pada pengobatan ataksia Friedreich, diikuti oleh program distrofi miotonik tipe-1 dan upaya penemuan untuk berbagai gangguan degeneratif serius lainnya yang disebabkan oleh perluasan pengulangan nukleotida. 		Pharmaceutical Preparations 367.88 1.43
223 US VSTM / Verastem, Inc. Pharmaceutical Preparations 662.61 1.42
224 US TBI / TrueBlue, Inc. Help Supply Services 175.17 1.42
225 US AIFU / AIFU Inc.
Fanhua Inc. adalah perusahaan jasa keuangan yang berbasis di Tiongkok yang terutama beroperasi di sektor asuransi. Sebagai penyedia terkemuka, perusahaan ini fokus pada distribusi beragam produk dan layanan asuransi. Penawarannya meliputi asuransi properti, kecelakaan, jiwa, dan kesehatan, yang disediakan melalui jaringan luas yang mencakup platform online dan agen offline. Fanhua memanfaatkan teknologi canggih untuk meningkatkan efisiensi dan keterlibatan pelanggan, memposisikan dirinya dengan kuat di pasar asuransi Tiongkok yang sedang berkembang. Proyek-proyek strategis perusahaan seringkali berputar di sekitar perluasan kemampuan digitalnya dan menjangkau segmen pelanggan yang belum tergarap untuk mempertahankan pertumbuhan dan profitabilitas dalam lanskap industri yang kompetitif. Strategi inovasi dan penetrasi pasar yang berkelanjutan ini menggarisbawahi komitmen Fanhua untuk mempertahankan posisinya sebagai pemain kunci di industri asuransi Tiongkok. 		Insurance Agents, Brokers, and Service 1.42
226 US KLTR / Kaltura, Inc.
Kaltura, Inc., headquartered in the United States, is a prominent player in the software and technology sector, specializing in video management and cloud TV solutions. The company provides a comprehensive suite of products designed to facilitate video hosting, streaming, and monetization, catering to a diverse clientele that includes educational institutions, media corporations, and enterprises. Key projects focus on enhancing online video experiences such as virtual classrooms, video portals, and live events, integrating advanced functionalities like AI-driven insights and analytics, customizable player designs, and robust security features. Kaltura's initiatives ensure high scalability and reliability, aiming to redefine user engagement and content delivery in a continuously evolving digital landscape. 		Prepackaged Software 225.03 1.42
227 US DIBS / 1stdibs.Com, Inc. Catalog and Mail-Order Houses 101.85 1.42
228 US DLTH / Duluth Holdings Inc.
Duluth Holdings Inc., based in the United States, operates primarily in the retail industry, specializing in clothing and tools designed for work, outdoor, and casual wear. Founded in 1989 and headquartered in Mount Horeb, Wisconsin, the company markets its products under the Duluth Trading brand. It is known for providing durable, functional, and innovative goods that cater to the requirements of tradespeople and outdoor enthusiasts. Duluth Holdings has expanded its market presence through a blend of online and physical store strategies, establishing numerous locations across various states. Key projects include the enhancement of their e-commerce platform and expansion of their physical retail footprint to increase direct-to-consumer sales channels. 		Apparel And Accessory Stores 131.59 1.41
229 US BIOX / Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp., headquartered in Rosario, Argentina, operates primarily in the agricultural biotechnology sector. The company develops and provides crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality. These solutions include seed treatments, genetic improvements, and crop protection products that enhance yields while reducing environmental impact. Key projects include the development of drought-resistant crops under the HB4 technology, which represents a significant advancement in agronomic traits for vital crops such as soybeans and wheat. Through strategic partnerships and advanced biotechnological research, Bioceres aims to address critical challenges in sustainable agriculture on a global scale. 		Agricultural Chemicals 170.82 1.40
230 US FF / FutureFuel Corp.
FutureFuel Corp., yang berbasis di Amerika Serikat, beroperasi terutama di industri manufaktur kimia, berfokus pada pengembangan dan produksi produk kimia yang beragam dan produk bahan bakar berbasis bio. Operasi perusahaan terutama berpusat di fasilitasnya di Batesville, Arkansas. FutureFuel Corp. mengkhususkan diri dalam manufaktur khusus (memproduksi bahan kimia untuk pelanggan tertentu) dan bahan kimia berkinerja tinggi, yang meliputi produk-produk seperti aktivator pemutih dan formulasi herbisida dan adjuvan milik perusahaan. Aspek penting dari portofolionya termasuk produksi biodiesel dan biofuel, yang menempatkannya di sektor energi berkelanjutan. Inisiatif strategis FutureFuel mencakup adaptasi terhadap permintaan pasar dalam energi bersih dan produksi kimia yang ramah lingkungan, sehingga memenuhi kebutuhan pelanggan industri dan tren keberlanjutan yang berpusat pada konsumen. 		Industrial Organic Chemicals 173.46 1.40
231 US TBLA / Taboola.com Ltd.
Taboola.com Ltd. is a digital advertising company based in Israel, specializing predominantly in providing a platform for content recommendations. It's well known for its unique model where it teams up with publishers and advertisers to deliver personalized content suggestions, often found at the bottom of articles on popular websites. Key to Taboola's operations is their proprietary algorithm which predicts interests and engagement of different audiences, thereby enhancing ad revenue for publishers while providing advertisers with targeted outreach capabilities. Their notable projects include acquisitions and partnerships with leading media companies worldwide, aimed at expanding their market presence and enhancing their technology stack to foster a more engaging user experience in the competitive internet advertising industry. 		Computer Programming, Data Processing, And Other Computer Related Services 1,001.18 1.40
232 US BTCM / BIT Mining Limited - Depositary Receipt (Common Stock)
BIT Mining Limited, based in China, operates primarily in the cryptocurrency sector with significant ventures into mining and related services. As a prominent player in the cryptocurrency industry, it focuses on the development and operation of cryptocurrency mining pools, particularly those involved with Bitcoin. BIT Mining has expanded its portfolio to include cryptocurrency mining data centers, demonstrating a strategic approach to leveraging global energy resources. The company has also ventured into cryptocurrency mining machine manufacturing, aiming to enhance the efficiency and profitability of its operations. Highlighting its growth and adaptability, BIT Mining continuously seeks international expansion, notably through investments in mining centers in overseas markets, thereby broadening its operational footprint and strengthening its market position. 		Finance Services 43.14 1.40
233 US ATHA / Athira Pharma, Inc. Biological Products, Except Diagnostic Substances (Biotech) 15.14 1.39
234 US INMB / INmune Bio, Inc. Biological Products, Except Diagnostic Substances (Biotech) 52.37 1.39
235 US ERAS / Erasca, Inc. Pharmaceutical Preparations 455.26 1.39
236 US CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
COMPASS Pathways plc is a health care company based in the United Kingdom, primarily focusing on the biotechnology industry. It specializes in developing therapies that address unmet needs within mental health care. COMPASS Pathways is notably recognized for its pioneering research in psilocybin therapy and its potential applications in treatment-resistant depression. One of their key projects is COMP360, a proprietary formulation of synthetic psilocybin, now advancing through clinical trials aimed at evaluating its safety and effectiveness. The company's efforts are part of a broader aim to innovate within psychiatric treatment modalities, contributing to evidence-based solutions that can significantly impact global mental health treatment paradigms. 		Pharmaceutical Preparations 481.50 1.39
237 US CGC / Canopy Growth Corporation
Canopy Growth Corporation, based in Canada, operates at the forefront of the global cannabis industry. Established as a medical marijuana producer, the company has expanded its reach to include a wide array of cannabis products, including dried flower, oil, capsules, and hemp. Key projects and initiatives include their partnership with Constellation Brands to delve into cannabis-infused beverages, and significant investments in research and development to innovate and scale up their product line. The firm focuses heavily on both the recreational and medical cannabis markets, leveraging state-of-the-art growing and production facilities to maintain and enhance their market position. Canopy Growth's strategy includes expanding its international presence, particularly in regions with evolving cannabis regulations. 		Medicinal Chemicals and Botanical Products 298.49 1.39
238 US TBHC / The Brand House Collective, Inc.
Kirkland's, Inc., yang berbasis di Amerika Serikat, beroperasi di industri ritel, yang mengkhususkan diri dalam produk dekorasi rumah. Perusahaan ini menawarkan berbagai macam barang dagangan termasuk furnitur, tekstil, dan berbagai aksesoris dekoratif. Strategi bisnisnya yang integral adalah toko-toko fisiknya yang berlokasi strategis di seluruh negeri, dilengkapi dengan platform e-commerce yang kuat yang memperluas jangkauan pasarnya. Proyek-proyek utama berpusat pada peningkatan kemampuan digital dan pengoptimalan rantai pasokannya untuk lebih memenuhi permintaan konsumen sambil mempertahankan efisiensi biaya. Inisiatif-inisiatif ini merupakan bagian dari tujuan Kirkland yang lebih luas untuk meningkatkan pengalaman pelanggan dan efektivitas operasional, memposisikan dirinya secara kompetitif dalam lingkungan ritel yang dinamis. 		Retail Stores, Not Elsewhere Classified 38.62 1.39
239 US UFI / Unifi, Inc. Textile Mill Products 82.26 1.39
240 US BW / Babcock & Wilcox Enterprises, Inc.
Babcock & Wilcox Enterprises, Inc., headquartered in the United States, operates primarily in the power generation sector, offering a variety of services and technologies to enhance the efficiency and environmental quality of energy production. The company has historically been pivotal in the design and manufacture of boilers and nuclear components, positioning itself as a leader in clean energy projects and services that support both fossil and renewable power generation. Noteworthy projects include advancements in biomass conversion technologies and environmental equipment for clean air and water. Babcock & Wilcox continue to expand their global footprint, undertaking strategic projects that leverage their expertise in engineering, technology, and manufacturing to address the evolving demands of the energy industry. 		Heating Equipment, Except Electric and Warm Air Furnaces 212.26 1.39
241 US GRWG / GrowGeneration Corp. Building Materials, Hardware, Garden Supply, And Mobile Home Dealers 90.55 1.39
242 US IGC / IGC Pharma, Inc.
IGC Pharma, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor bioteknologi, berfokus pada pengembangan dan komersialisasi terapi berbasis cannabinoid untuk kondisi medis yang saat ini memiliki pilihan pengobatan terbatas. Perusahaan ini aktif terlibat dalam proyek penelitian perintis yang berpusat pada penyakit Alzheimer dan kondisi neurologis lainnya. Salah satu usaha pentingnya melibatkan formulasi IGC-AD1 (Hyblonol), yang sedang dalam tahap uji klinis yang bertujuan untuk mengurangi gejala Alzheimer. Selain itu, portofolio IGC Pharma meluas ke pengembangan agen terapeutik baru yang dirancang untuk mengobati nyeri hebat dan kejang, mendukung posisinya sebagai inovator terkemuka dalam farmakologi cannabinoid di industri perawatan kesehatan. 		Pharmaceutical Preparations 36.35 1.38
243 US ANIX / Anixa Biosciences, Inc.
Anixa Biosciences, Inc., headquartered in the United States, operates in the biotechnology sector, primarily focusing on the development of innovative approaches in cancer treatment and infectious disease prevention. The company is engaged in advancing a diverse portfolio of projects including proprietary cancer vaccines and therapies that modulate key immune responses. Notably, Anixa’s research initiatives target breast cancer with a vaccine designed to prevent the recurrence of triple-negative breast cancer, a particularly aggressive form of the disease. Additionally, the company explores the therapeutic potential of chimeric endocrine receptor technology. Anixa is also developing a nasal vaccine for COVID-19, highlighting its dedication to addressing significant global health challenges. The company’s projects often involve collaborations with leading academic institutions and research organizations to facilitate the transition from scientific discovery to clinical application. 		Pharmaceutical Preparations 95.67 1.38
244 US MFH / Mercurity Fintech Holding Inc. 354.73 1.38
245 US LFWD / Lifeward Ltd. Orthopedic, Prosthetic, and Surgical Appliances and Supplies 8.30 1.38
246 US INCR / InterCure Ltd. Commercial Physical and Biological Research 1.38
247 US BGSF / BGSF, Inc.
BGSF, Inc., based in the United States, operates primarily in the workforce solutions sector. The company specializes in providing a diverse range of staffing and consulting services across multiple industries, with a significant emphasis on real estate, professional services, and light industrial sectors. BGSF’s approach involves strategic staffing solutions, workforce management, and outsourcing services designed to address the specific needs of its clients to enhance productivity and operational efficiency. Some of their key projects include tailored workforce solutions that integrate technology and expertise to streamline client staffing processes, thereby creating significant value in sectors like property management and IT services. These initiatives position BGSF not merely as a staffing agency, but as a comprehensive partner in workforce optimization. 		Help Supply Services 68.16 1.38
248 US AVTX / Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc., headquartered in the United States, operates within the biotechnology industry, focusing primarily on the development of transformative therapies for serious and rare diseases. A key aspect of its project portfolio includes innovative treatments targeting conditions such as autoimmune and rare diseases, where significant unmet medical needs exist. The company employs a robust, science-driven approach that emphasizes genetic insights and novel therapeutic pathways. Avalo Therapeutics' dedication to leveraging cutting-edge science to design and develop medications positions it distinctively for advancing treatments that can substantively improve patient outcomes in underserved medical areas, aligning its strategic initiatives with long-term health solutions and likely growth in its biotechnological endeavors. 		Pharmaceutical Preparations 125.71 1.38
249 US MOGO / Mogo Inc.
Mogo Inc. is a fintech company based in Canada. Specializing in personal finance, Mogo offers a wide range of financial solutions aimed at enhancing consumer financial health. These solutions encompass personal loans, identity fraud protection, mortgages, a Visa Prepaid Card, and a digital payments platform. Furthermore, Mogo extends into the cryptocurrency space, providing services that allow the buying and selling of cryptocurrencies. A key project for Mogo is its climate-conscious initiative, which includes offering carbon offset credits to engage their user base in environmental sustainability. The firm strives to integrate innovative technologies with financial services, capitalizing on the growing demand for digital financial products in Canada and beyond. 		Finance Services 43.72 1.37
250 US HLLY / Holley Inc.
Holley Inc., based in the United States, operates primarily within the automotive aftermarket industry. The company has established itself as a prominent developer and distributor of high-performance automotive parts, serving both automotive enthusiasts and professional racers. Holley’s product portfolio extends across a range of engine-related parts including fuel injection systems, carburetors, and exhaust systems. Key projects have centered on innovations in fuel system management and the development of high-efficiency air and exhaust flow systems in engines, all designed to enhance vehicle performance and efficiency. Holley's deep-rooted engagement with motorsports and muscle cars augments its brand in competitive automotive markets, marrying tradition with cutting-edge automotive technology. 		Motor Vehicle Parts and Accessories 460.23 1.37
251 US KTCC / Key Tronic Corporation
Key Tronic Corporation, yang berbasis di Amerika Serikat, beroperasi terutama di industri jasa manufaktur elektronik (EMS). Perusahaan ini mengkhususkan diri dalam menyediakan solusi desain, rekayasa, dan manufaktur terintegrasi kepada beragam klien di berbagai sektor, termasuk elektronik konsumen, telekomunikasi, dan produk industri. Dengan penekanan yang kuat pada rekayasa khusus dan berbagai layanan lengkap mulai dari perakitan produk hingga manajemen rantai pasokan, Key Tronic telah memantapkan dirinya sebagai pemain serbaguna yang mampu mengelola persyaratan manufaktur yang kompleks. Proyek-proyek utama biasanya melibatkan rekayasa presisi dan proses produksi yang rumit, yang menggarisbawahi komitmen perusahaan terhadap kualitas dan inovasi di bidang manufaktur teknologi. 		Printed Circuit Boards 34.22 1.37
252 US HYFT / ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a biotechnology company based in Canada that specializes in the discovery and development of novel antibody-based solutions. Operating primarily in the pharmaceutical sector, the company focuses on harnessing its proprietary platforms to advance monoclonal, bispecific, and other types of antibody therapies. It engages in comprehensive service offerings, ranging from target analysis to preclinical studies, serving a global clientele in the rapidly evolving therapeutic and diagnostic antibody industry. Key projects often involve partnerships with biopharma firms to address complex diseases such as cancer and autoimmune disorders. These collaborations are crucial in accelerating the pipeline from discovery through pre-clinical phases, positioning ImmunoPrecise as a valuable player in antibody research and development. 		Pharmaceutical Preparations 89.08 1.37
253 US VVPR / VivoPower International PLC Electric and Other Services Combined 1.36
254 US GANX / Gain Therapeutics, Inc. Pharmaceutical Preparations 54.16 1.36
255 US RMTI / Rockwell Medical, Inc.
Rockwell Medical, Inc., based in the United States, primarily operates within the healthcare sector, focusing on the development and marketing of innovative therapeutic products and services for patients suffering from chronic kidney disease (CKD). Central to their product lineup are dialysis concentrates, which are used in the dialysis process critical for patients undergoing treatment for end-stage renal disease (ESRD). Among their key products, Triferic, an FDA-approved iron therapy that treats iron deficiency in CKD patients, stands out. This unique therapy is administered through dialysate, directly substituting iron loss during dialysis, thereby maintaining hemoglobin without increasing iron stores, offering a distinctive approach to iron management in a dialysis setting. 		Pharmaceutical Preparations 55.43 1.36
256 US ZEPP / Zepp Health Corporation - Depositary Receipt (Common Stock) Electronic Computers 786.44 1.36
257 US ATXS / Astria Therapeutics, Inc. Pharmaceutical Preparations 424.95 1.35
258 US AREN / The Arena Group Holdings, Inc. Cable and Other Pay Television Services 303.46 1.35
259 US WPRT / Westport Fuel Systems Inc. Engines And Turbines 43.20 1.35
260 US DSX / Diana Shipping Inc.
Diana Shipping Inc. is a global provider of shipping transportation services, based in Athens, Greece. Founded in 1999, the company primarily operates in the dry bulk cargo sector, facilitating the marine transportation of commodities such as iron ore, coal, grain, and other materials essential for manufacturing and production. Diana Shipping Inc. focuses on owning and operating a fleet of dry bulk vessels, including Panamax, Kamsarmax, and Capesize ships. The company strategically manages its vessel investments and chartering activities to cater to the needs of the international shipping market. Diana Shipping’s operational strategy centers around maintaining a modern, high-quality fleet while leveraging its extensive industry expertise to enhance chartering services, thereby ensuring efficient and reliable transport solutions for its clientele. 		Deep Sea Foreign Transportation of Freight 183.71 1.35
261 US CNVS / Cineverse Corp.
Cineverse Corp., based in the United States, operates primarily within the entertainment industry, specifically focusing on digital cinema. The company has adeptly positioned itself in the provision of comprehensive digital cinema services, including distribution and event services that cater to major film studios and independent distributors. A key project for Cineverse Corp includes its involvement in advanced digital cinema technologies, emphasizing solutions for streamlined distribution and projection of movies across a broad network of theaters. This endeavor underscores the company's commitment to enhancing the cinema experience through technological innovations, thereby supporting its clientele in delivering high-quality entertainment to a global audience. 		Video Tape Rental 63.74 1.35
262 US NVCT / Nuvectis Pharma, Inc. Pharmaceutical Preparations 159.74 1.35
263 US CCO / Clear Channel Outdoor Holdings, Inc.
Clear Channel Outdoor Holdings, Inc., based in the United States, is a prominent player in the outdoor advertising industry. The company specializes in providing a diverse array of advertising platforms including billboards, street furniture, and transit displays across global markets. Clear Channel Outdoor is noted for leveraging innovative technology and analytics to deliver tailored advertising solutions that engage public audiences effectively. Key projects often involve the development and expansion of digital billboards and smart advertising solutions that integrate real-time data to enhance advertiser impact. The firm's strategic initiatives are primarily focused on expanding their digital inventory and enhancing programmatic advertising capabilities to capitalize on modern marketing trends and increase their geographical footprint in high-growth areas. 		Advertising 658.38 1.35
264 US VRAR / The Glimpse Group, Inc.
The Glimpse Group, Inc., headquartered in the United States, is a diversified Virtual Reality (VR) and Augmented Reality (AR) platform company, focused on leveraging these technologies to create innovative solutions across various industries. The company's primary industry revolves around the development and commercialization of immersive technology applications, aiming to enhance user experiences in fields such as education, training, marketing, and entertainment. Key projects by The Glimpse Group typically involve the development of proprietary VR and AR software and services, often tailored to the specific needs of enterprise clients, thereby embedding advanced technological tools into the workflow of conventional businesses and educational institutions to drive engagement, efficiency, and growth. 		Computer Programming Services 29.15 1.35
265 US CELU / Celularity Inc. Pharmaceutical Preparations 58.18 1.35
266 US PLCE / The Children's Place, Inc.
The Children's Place, Inc., yang berbasis di Amerika Serikat, beroperasi di industri ritel, terutama berfokus pada pakaian dan aksesoris anak-anak. Didirikan pada tahun 1969, perusahaan ini telah memantapkan dirinya sebagai pemain penting di sektor ini, menyediakan berbagai produk termasuk pakaian kasual, pakaian formal, dan alas kaki untuk anak-anak dari bayi baru lahir hingga pra-remaja. Selama bertahun-tahun, The Children's Place telah menerapkan strategi ritel multi-saluran, menggabungkan toko fisik dan kehadiran online yang kuat. Komitmen perusahaan terhadap transformasi digital terlihat melalui investasi besar dalam peningkatan platform online dan implementasi model operasional omni-channel terintegrasi. Strategi ini sangat berfokus pada pengoptimalan manajemen inventaris dan keterlibatan pelanggan melalui kemajuan teknologi. 		Family Clothing Stores 117.55 1.34
267 US NAK / Northern Dynasty Minerals Ltd.
Northern Dynasty Minerals Ltd., based in Vancouver, Canada, is a mining company primarily engaged in the exploration and development of mineral properties. The company's signature venture is the Pebble Project, located in the Bristol Bay region of Alaska, USA. This project, one of the largest undeveloped copper and gold deposits in the world, has been a focal point of environmental scrutiny and regulatory challenges due to its potential impact on the region's significant salmon ecosystem. Despite these hurdles, Northern Dynasty Minerals continues to pursue the development of the Pebble Project, aiming to balance substantial economic benefits against environmental and cultural concerns, embodying its complex role in the mining industry. 		Gold And Silver Mining 457.67 1.34
268 US IRS / IRSA Inversiones y Representaciones Sociedad Anónima - Depositary Receipt (Common Stock)
IRSA Inversiones y Representaciones Sociedad Anónima, based in Argentina, primarily operates within the real estate sector. The company has established a prominent presence in various facets of the industry including shopping mall development, office buildings, and luxury hotels across significant urban markets in Argentina. Key projects include the development and management of major commercial shopping centers, such as the Alto Palermo and Abasto malls in Buenos Aires, and involvement in upscale residential developments. Likewise, IRSA has diversified its investment portfolio by venturing into agricultural land development and production, further highlighting its comprehensive approach to real estate and investment in Argentina's dynamic market environments. 		Land Subdividers and Developers, Except Cemeteries 1.34
269 US RR / Richtech Robotics Inc. General Industrial Machinery and Equipment, Not Elsewhere 352.22 1.34
270 US NSPR / InspireMD, Inc.
InspireMD, Inc., headquartered in Tel Aviv, Israel, operates primarily in the medical device industry. The company specializes in developing and commercializing proprietary MicroNet stent platform technology, specifically designed for vascular and coronary disease prevention. A notable project is their CGuard Carotid Embolic Prevention System, designed to prevent stroke by trapping potential emboli. Additionally, the firm works on improving its MGuard Prime EPS, which is employed in cardiac procedures to prevent embolic showers associated with stenting. These innovative projects underscore InspireMD's commitment to enhancing patient outcomes in complex cardiovascular and neurovascular interventions, focusing on achieving global regulatory approvals to expand its market reach. 		Surgical and Medical Instruments and Apparatus 78.78 1.33
271 US CDZI / Cadiz Inc.
Cadiz Inc. adalah perusahaan pengembangan sumber daya lahan dan air Amerika yang berkantor pusat di Los Angeles, California. Berposisi terutama di industri lingkungan dan penyediaan air, proyek unggulan perusahaan ini melibatkan penyimpanan dan penyediaan air di wilayah Gurun Mojave, California. Terkenal sebagai Proyek Air Cadiz, inisiatif ini bertujuan untuk menangkap dan melestarikan miliaran galon air tanah yang seharusnya menguap, menyediakan sumber air berkelanjutan untuk komunitas dan bisnis pertanian di California Selatan. Selain itu, Cadiz Inc. mengeksplorasi dan telah mengembangkan usaha manajemen sumber daya lainnya yang selaras dengan model praktik berkelanjutan, mengatasi kebutuhan kritis di wilayah dengan pasokan air yang terbatas. Proyek-proyek strategis perusahaan terus memicu dialog publik, regulasi, dan ilmiah mengingat implikasi lingkungan yang signifikan dan kontribusinya terhadap manajemen sumber daya air negara bagian. 		Water Supply 290.73 1.33
272 US TNGX / Tango Therapeutics, Inc. Pharmaceutical Preparations 770.56 1.33
273 US BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
Baozun Inc., based in China, operates primarily within the e-commerce industry, serving as a leading solutions provider for brands aiming to establish and expand their online presence in the Chinese market. The company offers end-to-end services including IT solutions, store operations, digital marketing, customer services, warehousing, and fulfillment. A key project for Baozun is its omnichannel commerce solution, which integrates both online and offline consumer experiences, tailoring e-commerce solutions that drive growth across diverse digital platforms. This strategic approach not only optimizes brand performance but also enhances user engagement through advanced technology and data analytics platforms, supporting Baozun's position as a vital partner for brands navigating the complexities of the Chinese e-commerce landscape. 		Catalog and Mail-Order Houses 1.33
274 US AVIR / Atea Pharmaceuticals, Inc. Pharmaceutical Preparations 272.62 1.32
275 US ADV / Advantage Solutions Inc.
Advantage Solutions Inc., based in the United States, operates primarily in the outsourced sales and marketing industry, focusing largely on consumer goods and retail services. The company provides a comprehensive suite of innovative solutions to enhance the execution of marketing and merchandising initiatives for its clients. Key projects often involve data-driven strategies that integrate analytics to improve product launches, promotional activities, and supply chain efficiencies for major consumer brands. A significant part of its offerings includes technology-enabled services that streamline operations and drive ROI for stakeholders across various consumer sectors. Additionally, Advantage Solutions specializes in tailored marketing programs that help manufacturers and retailers optimize market reach and consumer engagement. 		Business Services, Not Elsewhere Classified 575.54 1.32
276 US III / Information Services Group, Inc.
Information Services Group, Inc., based in the United States, is a leading global technology research and advisory firm. Operating in the information technology services industry, the company specializes in digital transformation services, including expertise in automation, cloud-based services, and data analytics. ISG provides strategic guidance, operational advice, and implementation support to both public and private sector organizations, aiding them in maximizing efficiency and achieving competitive advantages within their markets. One of their key projects includes offering managed governance and risk services designed to optimize IT investment outcomes. The firm often collaborates with businesses to restructure their IT operations, enhance technological capabilities, and navigate complex digital transitions, positioning themselves as essential partners in enterprise growth and innovation. 		Management Consulting Services 253.44 1.31
277 US FTHM / Fathom Holdings Inc. Real Estate Agents and Managers 55.52 1.31
278 US GHRS / GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. 		Pharmaceutical Preparations 870.27 1.30
279 US SQNS / Sequans Communications S.A. - Depositary Receipt (Common Stock)
Sequans Communications S.A., based in Paris, France, is a notable player in the semiconductor industry, specializing in the design, development, and supply of cellular chipset solutions for massive, broadband, and critical IoT applications. The company's products are pivotal in facilitating efficient wireless broadband access, particularly for Internet of Things (IoT) devices across a spectrum of markets including telecommunications, networking, and automotive industries. Sequans has leveraged its technical expertise to develop a range of 5G and 4G chips, with projects that include Monarch 2 for LTE-M and NB-IoT applications, and Cascode for broadband high performance 5G devices. Through strategic partnerships and continuous innovation, Sequans remains at the forefront of facilitating advanced connectivity solutions for increasingly interconnected technology ecosystems. 		Semiconductors and Related Devices 21.92 1.30
280 US SATL / Satellogic Inc. 368.36 1.30
281 US OABI / OmniAb, Inc. Commercial Physical and Biological Research 211.05 1.30
282 US KOD / Kodiak Sciences Inc.
Kodiak Sciences Inc., based in the United States, operates primarily within the biotechnology industry, focusing on innovative therapeutics for treating chronic, high-prevalence retinal diseases. A key aspect of its project portfolio includes the development of the ABC Platform, designed to enhance the efficacy and durability of biologic therapies for retinal diseases. Notably, Kodiak Sciences is advancing KSI-301, a novel antibody biopolymer conjugate, through pivotal studies as a potential treatment for conditions such as wet age-related macular degeneration and diabetic eye diseases. This strategic focus underscores the company's commitment to addressing significant unmet medical needs in the ophthalmology sector, leveraging advanced science to improve patient outcomes. 		Biological Products, Except Diagnostic Substances (Biotech) 555.76 1.30
283 US DOMH / Dominari Holdings Inc.
Dominari Holdings Inc. is a diversified investment company based in the United States. The company operates primarily in the financial services industry, focusing on wealth management, merchant banking, and strategic investment initiatives. One of its key projects involves deploying innovative financial products designed to solve complex liquidity issues among emerging enterprises. Additionally, Dominari Holdings Inc. is actively engaged in developing proprietary hedge fund strategies that diversify and minimize risk for investors. The company has gained recognition for its holistic investment philosophy and has been involved in several strategic acquisitions, aligning itself with growth sectors such as technology and clean energy, which further enable it to extend its market influence and value creation capacities. 		Security Brokers, Dealers, and Flotation Companies 88.98 1.29
284 US ADSE / ADS-TEC Energy PLC
ADS-TEC Energy PLC adalah perusahaan yang berbasis di Jerman yang beroperasi terutama di sektor energi dengan fokus pada pengembangan dan manufaktur solusi penyimpanan energi berbasis baterai. Perusahaan ini mengkhususkan diri dalam menawarkan teknologi yang mendukung integrasi sumber energi terbarukan ke dalam infrastruktur jaringan yang ada, meningkatkan efisiensi dan stabilitas. Proyek-proyek utama meliputi berbagai sistem penyimpanan baterai dan solusi pengisian cepat untuk kendaraan listrik yang dirancang untuk mengurangi dampak pengisian daya pada jaringan listrik. ADS-TEC Energy patut dicatat atas kontribusinya yang signifikan terhadap kemajuan teknologi penyimpanan energi, yang memainkan peran penting dalam transisi menuju sistem energi yang berkelanjutan dan terdesentralisasi. Penawaran perusahaan melayani berbagai aplikasi termasuk solusi industri, komersial, dan mobilitas. 		Miscellaneous Transportation Equipment 1.29
285 US PSNY / Polestar Automotive Holding UK PLC - Depositary Receipt (Common Stock)
Polestar Automotive Holding UK PLC, headquartered in the United Kingdom, operates prominently within the automotive industry, focusing chiefly on electric vehicles (EVs). As a progressive manufacturer, Polestar is distinguished by its commitment to innovation and sustainability, aiming to improve environmental impact through cutting-edge technologies in electric mobility. Key projects include its lineup of high-performance electric cars, such as the Polestar 1 and Polestar 2 models, which showcase advancements in EV technology and design. The company actively explores developments in battery technology and autonomous driving features, enhancing its competitiveness in the global market for luxury electric vehicles. Polestar's strategic initiatives emphasize both performance and eco-friendly automotive solutions, positioning it as a leader in the transition towards more sustainable transportation. 		Blank Check 2,119.29 1.29
286 US NRGV / Energy Vault Holdings, Inc. Miscellaneous Electrical Machinery, Equipment, and Supplies 331.02 1.29
287 US CBLL / CeriBell, Inc. 431.51 1.29
288 US FLL / Full House Resorts, Inc.
Full House Resorts, Inc., based in the United States, operates within the gaming industry, predominantly focusing on regional casino properties. The company is vested in the development and management of gaming facilities that include casinos, related hotel and entertainment facilities across multiple states. Key projects under its portfolio include the Silver Slipper Casino and Hotel in Mississippi, Bronco Billy's Casino and Hotel in Colorado, Rising Star Casino Resort in Indiana, and Stockman’s Casino in Nevada. Additionally, Full House is at the forefront of launching The Temporary by American Place in Waukegan, Illinois, marking a significant expansion move that anticipates an increase in visitor influx and revenue. These projects underscore the company's strategic initiative to tap into diverse regional markets, strengthening its market presence in the U.S. gaming sector. 		Hotels and Motels 122.95 1.29
289 US UPXI / Upexi, Inc. Finance Services 8.64 1.29
290 US SYPR / Sypris Solutions, Inc. Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products 48.36 1.29
291 US XGN / Exagen Inc.
Exagen Inc. is a healthcare company based in the United States, specifically incorporated in Delaware and operationally headquartered in San Diego, California. Operating primarily within the biotechnology industry, Exagen is chiefly dedicated to developing and commercializing transformative diagnostic and healthcare solutions for autoimmune diseases. The company is particularly renowned for its Avise® diagnostic tests, which utilize proprietary biomarkers and algorithms to differentiate, prognose, and monitor autoimmune conditions, such as lupus and rheumatoid arthritis. By focusing on precision medicine, Exagen aims to improve patient outcomes and reduce healthcare costs through early and accurate disease detection and targeted therapy selections. This strategic approach leverages cutting-edge science to meet critical needs within the autoimmune disease community. 		Medical Laboratories 213.17 1.29
292 US GALT / Galectin Therapeutics Inc.
Galectin Therapeutics Inc., yang berbasis di Amerika Serikat, adalah perusahaan bioteknologi yang fokus pada pengembangan terapi yang menargetkan protein galectin untuk mengobati penyakit fibrotik dan penyakit lainnya. Proyek utama perusahaan ini melibatkan senyawa milik sendiri, GR-MD-02, yang dirancang untuk menghambat galectin-3, protein yang terlibat dalam fibrosis (pembentukan jaringan parut) dan kanker. Galectin Therapeutics Inc. aktif terlibat dalam berbagai uji klinis, terutama berfokus pada pengobatan kondisi seperti steatohepatitis non-alkohol (NASH) dengan fibrosis lanjut dan sirosis. Selain itu, perusahaan ini sedang mengeksplorasi potensi terapeutik penghambat galectin-nya pada penyakit lain yang ditandai dengan fibrosis berat. Dalam upayanya, Galectin Therapeutics berupaya mengembangkan intervensi terapeutik baru yang dapat memberikan manfaat klinis yang signifikan di bidang yang saat ini kekurangan pengobatan yang efektif. 		Pharmaceutical Preparations 294.23 1.29
293 US WRAP / Wrap Technologies, Inc. Ordnance And Accessories, Except Vehicles And Guided Missiles 86.24 1.29
294 US MIST / Milestone Pharmaceuticals Inc. Pharmaceutical Preparations 119.20 1.29
295 US LWLG / Lightwave Logic, Inc. Miscellaneous Plastics Products 412.28 1.28
296 US CTXR / Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc., based in the United States, operates primarily in the biopharmaceutical industry, focusing on developing and commercializing critical care products with a strong emphasis on anti-infectives, cancer care, and unique prescription products. Notably, Citius is advancing a diversified pipeline of products, including Mino-Lok®, an antibiotic lock solution aimed at treating patients with catheter-related bloodstream infections. Another significant project is Halo-Lido, formulated to provide symptomatic relief for hemorrhoids. These initiatives reflect the company's strategic focus on innovative therapies that address significant unmet medical needs in specialized areas of treatment, positioning Citius Pharmaceuticals as a noteworthy player in the development of advanced patient care solutions. 		Pharmaceutical Preparations 17.80 1.28
297 US MTSR / Metsera, Inc. 3,758.31 1.28
298 US LXRX / Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., yang berkantor pusat di Amerika Serikat, beroperasi di sektor bioteknologi, terutama berfokus pada pengembangan dan komersialisasi pengobatan terobosan untuk penyakit manusia. Perusahaan ini telah memfokuskan upayanya pada diabetes dan penyakit kardiovaskular, di antara kondisi kesehatan serius lainnya. Proyek utama mereka termasuk pengembangan sotagliflozin, obat yang dirancang untuk mengobati diabetes dengan meningkatkan kontrol glikemik tanpa memerlukan insulin. Perusahaan memanfaatkan pemahaman bioinformatika dan genetika yang unik untuk mempelopori obat-obatan ini, bertujuan untuk memenuhi kebutuhan medis yang belum terpenuhi secara signifikan di bidang penyakit kronis. Lexicon Pharmaceuticals telah membangun saluran pengembangan obat yang kuat yang berada dalam berbagai tahap pengembangan klinis, memperkuat komitmennya terhadap inovasi dalam solusi perawatan kesehatan terapeutik. 		Pharmaceutical Preparations 399.74 1.28
299 US BTCS / BTCS Inc.
BTCS Inc. is a U.S.-based company situated within the burgeoning blockchain technology sector. Primarily, it focuses on digital asset ecosystems and related technologies. A key player in the validation of transactions on blockchain networks, BTSC Inc. specializes in crypto staking on various blockchain infrastructure projects. This operation not only supports the underlying blockchain technology but also allows the company to generate revenue through rewards derived from the staking processes. Incredible growth potential rests on BTCS’s ability to expand its staking operations and investments in supportive technology for the blockchain space, which in turn augments its operational footprint and market influence in a rapidly evolving industry. 		Finance Services 92.60 1.27
300 US NGNE / Neurogene Inc. Pharmaceutical Preparations 284.67 1.27
301 US TWIN / Twin Disc, Incorporated General Industrial Machinery And Equipment 183.96 1.27
302 US PROF / Profound Medical Corp. Surgical and Medical Instruments and Apparatus 124.12 1.27
303 US CHGG / Chegg, Inc.
Chegg, Inc., based in the United States, operates primarily in the education technology industry. Established to provide online textbook rentals, the company has significantly expanded its range of offerings. Chegg now provides a comprehensive suite of services designed to support students, including homework help, online tutoring, and test preparation platforms. Key projects arguably revolve around its digital subscription services, like Chegg Study and Chegg Tutor, which leverage advanced technology tools to offer tailored learning solutions. The company strategically integrates adaptive learning technologies to enhance educational accessibility and effectiveness, reflecting its commitment to breaking down barriers in the education sector and providing students with supportive learning environments. 		Educational Services 184.37 1.27
304 US ABAT / American Battery Technology Company 213.03 1.27
305 US RILY / B. Riley Financial, Inc.
B. Riley Financial menyediakan solusi layanan keuangan yang dirancang khusus untuk memenuhi kebutuhan penggalangan modal, bisnis, operasional, dan konsultasi keuangan klien dan mitranya. Anak perusahaan B. Riley menawarkan berbagai kemampuan yang mencakup perbankan investasi dan pialang institusional, pengelolaan kekayaan pribadi dan investasi, konsultasi keuangan, restrukturisasi perusahaan, manajemen operasional, risiko dan kepatuhan, uji tuntas, akuntansi forensik, dukungan litigasi, penilaian dan valuasi, layanan lelang dan likuidasi. 		Investment Advice 1.27
306 US SATS / EchoStar Corporation
EchoStar Corporation, based in the United States, is a prominent player in the global satellite communications sector. Specializing in satellite service operations, EchoStar provides satellite and video delivery solutions both within the U.S. and internationally. Key projects and services include broadband satellite technologies and services for home and office, satellite operations, and the provision of equipment necessary for satellite-based services. The company also focuses on offering Satellite Service solutions and manages a fleet of satellites through its Hughes Network Systems and EchoStar Satellite Services business segments. Through strategic initiatives, such as the expansion of its internet services and collaborations with other communication companies, EchoStar continues to enhance its comprehensive portfolio of satellite services, reinforcing its role as a major entity in the technology and communication industries. 		Communications Services, Not Elsewhere Classified 10,514.18 1.27
307 US CHRS / Coherus Oncology, Inc.
Coherus BioSciences, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di industri bioteknologi, berfokus pada pengembangan dan komersialisasi terapi biosimilar. Perusahaan ini bertujuan untuk menantang tingginya biaya pengobatan biologis dalam onkologi dan penyakit autoimun, menawarkan akses pasien yang lebih terjangkau melalui pengurangan biaya perawatan. Proyek-proyek utama meliputi UDENYCA, biosimilar untuk Neulasta, yang membantu mengurangi risiko infeksi selama kemoterapi dengan meningkatkan sel darah putih. Lebih lanjut, Coherus terlibat dalam pengembangan lini produk yang mencakup biosimilar dari obat-obatan terkemuka seperti Humira dan Avastin. Inisiatif-inisiatif ini mencerminkan fokus strategisnya untuk menjadi pemain signifikan di pasar biosimilar, yang berpotensi transformatif bagi perawatan pasien dan ekonomi kesehatan. 		Biological Products, Except Diagnostic Substances (Biotech) 150.51 1.26
308 US BKKT / Bakkt Holdings, Inc. Finance Services 59.42 1.26
309 US OM / Outset Medical, Inc. Electromedical and Electrotherapeutic Apparatus 248.90 1.26
310 US MEIP / MEI Pharma, Inc.
MEI Pharma, Inc., based in the United States, specializes in the pharmaceutical industry with a strong focus on developing novel therapies for cancer treatment. The company's robust pipeline emphasizes oncology, where it is committed to advancing targeted therapeutics and bolstering its presence in this critical healthcare segment. Key projects include clinical-stage drug candidates such as Pracinostat, which is being developed as a treatment for various hematologic diseases and solid tumors. MEI Pharma has forged strategic partnerships to drive its research and development efforts, aiming to produce innovative, efficacious cancer treatments. This strategic approach allows MEI Pharma to not only expand its clinical reach but also enhances its potential market impact through advanced therapeutic options. 		Pharmaceutical Preparations 28.28 1.26
311 US NMRA / Neumora Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 272.88 1.26
312 US BZFD / BuzzFeed, Inc. Communications Services, Not Elsewhere Classified 68.89 1.26
313 US REPL / Replimune Group, Inc.
Replimune Group, Inc. adalah perusahaan bioteknologi yang berbasis di Amerika Serikat, yang terutama mengkhususkan diri dalam pengembangan terapi imunogen onkolitik. Perusahaan ini bertujuan untuk berinovasi dalam pengobatan kanker melalui platform miliknya yang menggunakan virus hasil rekayasa genetika yang dirancang untuk secara selektif membunuh sel tumor, meningkatkan respons alami sistem kekebalan tubuh, dan menginduksi respons anti-tumor sistemik yang kuat. Salah satu proyek utamanya termasuk pengembangan RP1, terapi investigasi yang telah memasuki uji klinis dan menunjukkan potensi dalam mengobati berbagai jenis kanker termasuk melanoma, kanker kulit non-melanoma, dan kanker kandung kemih. Fokus Replimune pada pemanfaatan dan peningkatan kemampuan bawaan tubuh untuk melawan kanker menempatkannya sebagai entitas penting di sektor onkologi. 		Biological Products, Except Diagnostic Substances (Biotech) 492.13 1.25
314 US IMAB / I-Mab - Depositary Receipt (Common Stock)
I-Mab, based in China, operates as a clinical-stage biopharmaceutical company primarily involved in the discovery, development, and potential commercialization of innovative biologics in the therapeutic area of immuno-oncology and autoimmune diseases. As a player in the biotech industry, I-Mab stands out due to its robust pipeline that includes several late-stage assets and other drug candidates in various stages of clinical trials globally. Notably, the company is committed to addressing critical unmet medical needs by advancing a wave of novel therapies, focusing on bringing pioneering treatments to patients worldwide. The strategic deployment of its resources underscores its dedication to achieving milestones in biologic therapy innovations, exemplified by its continued progression to phase III clinical trials in some candidate drugs. 		Pharmaceutical Preparations 360.27 1.25
315 US BLND / Blend Labs, Inc. Computer Programming, Data Processing, And Other Computer Related Services 1,048.01 1.25
316 US STIM / Neuronetics, Inc.
Neuronetics, Inc., based in the United States, operates primarily within the medical device industry, focusing on pioneering treatments for psychiatric disorders. A notable project of Neuronetics is the development of its proprietary NeuroStar Advanced Therapy system, a non-invasive treatment that utilizes transcranial magnetic stimulation (TMS) technology to alleviate depression. Established with an intention to innovate solutions for mental health issues, the company notably addresses conditions that are often resistant to conventional treatments. Neuronetics’ role in advancing neuromodulation therapies positions it as a key player in the mental health sector, contributing to broader healthcare objectives by providing clinically significant improvements in patient outcomes through technology-driven treatments. 		Surgical and Medical Instruments and Apparatus 213.21 1.25
317 US PSNL / Personalis, Inc.
Personalis, Inc. is a genomics-based precision medicine company headquartered in the United States. Founded in 2011, the company primarily serves the biopharmaceutical industry with a focus on providing advanced genomic sequencing and analytics. Key to its operations is the Personalis NeXT Platform, designed to offer comprehensive molecular data of cancer tissues, which is crucial for the development of personalized cancer vaccines and other targeted therapies. Personalis extends its expertise beyond oncology, supporting population sequencing projects and clinical trials globally. By integrating innovative technology and extensive genomic intelligence, Personalis, Inc. plays a pivotal role in the advancement of precision medicine, striving to enhance personalized treatment approaches across various diseases. 		Medical Laboratories 464.97 1.24
318 US NPWR / NET Power Inc. Electrical Industrial Apparatus 170.56 1.24
319 US ONDS / Ondas Holdings Inc.
Ondas Holdings Inc., based in the United States, operates primarily in the technology sector, focusing on wireless communications systems and solutions. The company specializes in developing proprietary, wide-area broadband networks designed to support industrial IoT applications through its subsidiary, Ondas Networks. These networks cater to vital industries such as utilities, transportation, and government services. Additionally, Ondas Holdings has expanded into the drone space with its acquisition of American Robotics, a company engaged in the development of fully-automated commercial drone systems. This strategic move diversifies Ondas' portfolio into autonomous aerial technology, aiming to enhance operational efficiencies and data collection capabilities across various sectors. Through these initiatives, Ondas Holdings is positioning itself as a leader in scalable, high-performance wireless communications and autonomous drone technology. 		Radio and Television Broadcasting and Communications Equipment 1,165.97 1.23
320 US CMPX / Compass Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 476.38 1.23
321 US RNAC / Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor bioteknologi, berfokus pada pengembangan terapi inovatif. Perusahaan ini menonjol karena karya perintisnya dalam terapi sel rekayasa yang menargetkan penyakit autoimun, kanker, dan kondisi pernapasan. Aspek penting dari pendekatan Cartesian Therapeutics melibatkan penggunaan teknologi mRNA untuk memodifikasi sel, yang bertujuan untuk respons pengobatan yang lebih terkontrol dan kuat. Di antara proyek-proyek utamanya adalah terapi target untuk miastenia gravis dan sindrom gangguan pernapasan akut, yang mencerminkan komitmennya untuk mengatasi tantangan medis yang kompleks. Perusahaan ini memanfaatkan metodologi ilmiah mutakhir untuk memajukan lini produknya, menunjukkan komitmen yang kuat untuk merevolusi lanskap pengobatan melalui terobosan bioteknologi. 		Pharmaceutical Preparations 277.16 1.23
322 US PLX / Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., based in Israel, operates within the biopharmaceutical sector, focusing primarily on the development and commercialization of recombinant therapeutic proteins through its proprietary ProCellEx plant cell-based expression system. The company targets a range of complex diseases, including rare disorders. A prominent project of Protalix is Elelyso, an enzyme replacement therapy approved for Gaucher disease, developed in partnership with Pfizer. Another key initiative includes advancing treatments for Fabry disease and other conditions where traditional enzyme replacement therapies are employed. The company's novel technology and strategic partnerships underline its position as a pioneer in leveraging plant biotechnology for biopharmaceutical applications, aligning its product pipeline directly with significant, unmet medical needs. 		Biological Products, Except Diagnostic Substances (Biotech) 123.19 1.23
323 US TELA / TELA Bio, Inc. Surgical and Medical Instruments and Apparatus 63.33 1.22
324 US CTOS / Custom Truck One Source, Inc. Equipment Rental and Leasing, Not Elsewhere Classified 1,379.75 1.22
325 US VFS / VinFast Auto Ltd. 7,823.33 1.22
326 US FFAI / Faraday Future Intelligent Electric Inc.
Faraday Future Intelligent Electric Inc., yang berbasis di Amerika Serikat, beroperasi di industri otomotif, yang mengkhususkan diri dalam desain dan pembuatan kendaraan listrik (EV). Strategi pengembangannya yang integral adalah promosi teknologi dan perangkat lunak canggih miliknya sendiri, yang bertujuan untuk merevolusi solusi mobilitas. Salah satu proyek andalannya termasuk FF 91, sebuah SUV listrik mewah yang dirancang untuk bersaing langsung dengan pemain utama di pasar EV dengan menawarkan performa superior, teknologi pengalaman pengguna yang inovatif, dan kemampuan mengemudi otonom. Perusahaan telah fokus pada integrasi fitur unik seperti internet, AI, dan komponen teknologi canggih lainnya, memposisikan dirinya sebagai pelopor di segmen EV mewah dan menekankan solusi transportasi berkelanjutan dan futuristik. 		Motor Vehicles and Passenger Car Bodies 222.14 1.22
327 US DBI / Designer Brands Inc.
Designer Brands Inc., yang berkantor pusat di Columbus, Ohio, AS, merupakan pemain terkemuka di sektor alas kaki dan aksesoris, beroperasi sebagai perancang, produsen, dan pengecer. Perusahaan ini memiliki portofolio merek milik dan berlisensi yang luas, melayani pasar yang beragam melalui jaringan toko ritelnya yang luas dan kehadiran online yang agresif. Penting bagi upaya strategisnya adalah perluasan penawaran Merek Eksklusifnya dan kemajuan signifikan dalam transformasi digital, yang bertujuan untuk meningkatkan keterlibatan konsumen dan efisiensi operasional. Kelincahan Designer Brands dalam beradaptasi dengan tren pasar yang berubah, ditambah dengan fokusnya pada strategi distribusi dan pemasaran yang inovatif, menggarisbawahi komitmennya untuk mempertahankan keunggulan kompetitif dalam lanskap ritel yang dinamis. 		Shoe Stores 230.03 1.22
328 US ATOS / Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc., based in the United States, is a clinical-stage biopharmaceutical company focused on developing innovative therapies in oncology and infectious diseases. Notably, the company has concentrated its efforts on breast cancer treatments and other significant unmet medical needs. A prominent project includes the development of Endoxifen, an oral formulation designed to reduce mammographic breast density and treat breast cancer. Additionally, Atossa is exploring novel therapeutic options for severe COVID-19, aiming to enhance the healthcare community's ability to combat this and potentially future pandemics. The company's strategic initiatives are geared towards advancing their proprietary therapeutics from concept through clinical development, with an emphasis on addressing critical treatment gaps in global health. 		Pharmaceutical Preparations 101.81 1.21
329 US PRQR / ProQR Therapeutics N.V.
ProQR Therapeutics N.V. is a biopharmaceutical company based in the Netherlands, primarily focused on developing transformative RNA therapies for severe genetic rare diseases. ProQR leverages its proprietary technology platforms to enhance RNA molecules for specific therapeutic targeting. A notable project includes their lead compound, sepofarsen, designed for the treatment of Leber’s congenital amaurosis, an inherited form of blindness. Additionally, the company is advancing a broad pipeline that includes potential treatments for cystic fibrosis and dystrophic epidermolysis bullosa. ProQR’s strategic approach combines rigorous scientific research with a commitment to addressing unmet medical needs in the area of genetic disorders, aiming to offer innovative solutions that significantly improve patient care. 		Pharmaceutical Preparations 260.20 1.21
330 US VUZI / Vuzix Corporation Radio and Television Broadcasting and Communications Equipment 187.17 1.21
331 US CPSH / CPS Technologies Corporation Pottery And Related Products 49.38 1.21
332 US ZBIO / Zenas BioPharma, Inc. 863.24 1.21
333 US QNCX / Quince Therapeutics, Inc. Biological Products, Except Diagnostic Substances (Biotech) 86.87 1.21
334 US TSHA / Taysha Gene Therapies, Inc. Biological Products, Except Diagnostic Substances (Biotech) 915.01 1.20
335 US TGEN / Tecogen Inc.
Tecogen Inc. is an American company based in Waltham, Massachusetts, primarily engaged in the design, manufacture, sale, and maintenance of cogeneration products, including combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational, and industrial use. The company’s key projects typically focus on innovative clean energy solutions, emphasizing energy cost reduction and carbon footprint minimization for its clients. Tecogen's technology portfolio includes advanced ultra-low-emission control technologies integrated into their InVerde, TecoChill, and Ilios branded products. These installations are significant in light-sensitive environments such as hospitals, hotels, and educational institutions, demonstrating Tecogen's commitment to reliable and environmentally sustainable energy production. 		Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment 181.05 1.20
336 US SY / So-Young International Inc. - Depositary Receipt (Common Stock) Computer Processing and Data Preparation and Processing Services 372.45 1.19
337 US ANRO / Alto Neuroscience, Inc. Pharmaceutical Preparations 99.63 1.19
338 US MVIS / MicroVision, Inc.
MicroVision, Inc. adalah perusahaan teknologi Amerika yang berbasis di Redmond, Washington, yang terutama bergerak dalam pengembangan teknologi pemindaian laser untuk proyeksi, penginderaan 3D, dan pengambilan gambar. Perusahaan ini berfokus pada produksi sistem tampilan dan penginderaan laser mini berdasarkan teknologi pemindaian PicoP® miliknya, yang mengintegrasikan MEMS (Micro-Electrical Mechanical Systems), dioda laser, optik, dan elektronik untuk menciptakan sistem tampilan dan pencitraan yang ringkas dan beresolusi tinggi. Proyek-proyek utama biasanya melibatkan aplikasi dalam sensor lidar otomotif, sistem realitas tertambah, dan perangkat portabel. MicroVision bertujuan untuk berinovasi dalam bidang optoelektronik yang berkembang pesat, berkontribusi langsung pada sektor-sektor yang membutuhkan presisi, miniaturisasi, dan peningkatan fungsionalitas dalam teknologi pencitraan. 		Electronic Components, Not Elsewhere Classified 283.94 1.19
339 US STEM / Stem, Inc.
Stem, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor energi, berfokus pada solusi penyimpanan energi cerdas dan teknologi berbasis perangkat lunak. Perusahaan ini memainkan peran penting dalam evolusi sektor energi terbarukan dengan menyediakan sistem penyimpanan energi canggih dan platform analitik perangkat lunak, yang dikenal sebagai Athena, untuk meningkatkan efisiensi dan keandalan energi. Proyek-proyek Stem sebagian besar terdiri dari penyebaran solusi penyimpanan baterai skala besar dan pemanfaatan pembelajaran mesin untuk mengoptimalkan penggunaan energi dan pengurangan biaya bagi bisnis dan jaringan listrik. Kolaborasi utama meliputi kemitraan dengan penyedia energi dan perusahaan teknologi terkemuka untuk mendorong interaktivitas jaringan dan mengintegrasikan energi terbarukan, yang menunjukkan komitmennya untuk mengubah cara energi didistribusikan dan dikonsumsi secara global. 		Miscellaneous Electrical Machinery, Equipment, and Supplies 116.10 1.19
340 US GPRK / GeoPark Limited
GeoPark Limited is an oil and gas exploration and production company based in Bermuda, primarily operating in Latin America. Active in the industry since 2002, the company's core activities center around the exploration, development, and production of oil and natural gas reserves. Key countries of operation include Colombia, Ecuador, Chile, Brazil, and Argentina. GeoPark has made significant strides in its project portfolio, with notable developments like the Llanos 34 block in Colombia, which has been a major contributor to its production growth. The company's strategic focus on sustainable and efficient operations has allowed it to establish a resilient and growing presence in the region's energy sector, navigating the complex challenges associated with hydrocarbon extraction and market fluctuations. 		Crude Petroleum and Natural Gas 327.45 1.19
341 US SANA / Sana Biotechnology, Inc. Biological Products, Except Diagnostic Substances (Biotech) 682.31 1.19
342 US OPTT / Ocean Power Technologies, Inc.
Ocean Power Technologies, Inc., based in the United States, is a pioneering company within the renewable energy sector, specifically in the industry of wave energy conversion. The firm primarily focuses on designing and manufacturing innovative systems that harness ocean wave energy to generate reliable and environmentally friendly electricity. A key project of the company includes its flagship PB3 PowerBuoy system, which captures wave energy to power subsea equipment, sensor arrays, and remote oceanographic data collection. Ocean Power Technologies' offerings underscore a commitment to sustainable energy solutions and have applications across various sectors, including defense, oil and gas, and scientific research, broadening the practical utilization of renewable energy resources in tackling energy challenges globally. 		Electric Services 85.51 1.19
343 US DHC / Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust based in the United States, specifically focused on owning and managing healthcare-related properties. Primarily operating within the healthcare sector, its portfolio comprises properties across various categories including medical office buildings, inpatient rehabilitation hospitals, and life science properties. The trust’s strategy is centered on leveraging the growing demand for healthcare infrastructure by acquiring, developing, and managing facilities in high-growth areas. Key projects include strategic redevelopments and enhancements aimed at boosting facility value and attractability to tenants, particularly in high-tech and high-potential markets. Diversified Healthcare Trust's investment approach underpins its mission to provide well-maintained and strategically located healthcare facilities that meet the evolving needs of its tenants and their patients. 		Real Estate Investment Trusts 997.07 1.19
344 US RAPT / RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc., based in the United States, operates within the biotechnology industry, specializing in the discovery and development of oral small molecule therapies for patients suffering from systemic inflammatory diseases and cancer. The company leverages its proprietary discovery platform to target specific molecules that modulate the immune system, focusing notably on TH1 and TH17 driven diseases. Key projects at RAPT include the development of treatments such as FLX475, targeting T cell trafficking for various cancers, and RPT193, aimed at addressing inflammatory diseases like atopic dermatitis. This strategic focus on immune-driven conditions positions RAPT Therapeutics to potentially impact a significant patient demographic across multiple disease areas. 		Pharmaceutical Preparations 217.95 1.19
345 US IRBT / iRobot Corporation
iRobot Corporation, yang berbasis di Amerika Serikat, beroperasi di industri elektronik konsumen dan mengkhususkan diri dalam desain dan manufaktur robot untuk penggunaan domestik dan militer. Terkenal dengan robot pembersih vakum Roomba-nya, perusahaan ini telah secara signifikan memengaruhi otomatisasi rumah melalui pengembangan teknologi otonom yang ditujukan untuk memudahkan tugas-tugas rumah tangga sehari-hari. Di luar produk konsumen, iRobot telah terlibat dalam beberapa proyek penting di sektor pertahanan, menciptakan teknologi robot yang dirancang untuk pengintaian dan penjinakan bom. Pendekatan ganda ini—melayani konsumen sehari-hari dan kontrak pemerintah—menegaskan posisi strategis iRobot dalam bidang robotika yang terus berkembang, terus berinovasi untuk memperluas jangkauan produk dan pasar sambil meningkatkan efisiensi operasional melalui otomatisasi. 		Household Appliances 101.44 1.18
346 US CMTG / Claros Mortgage Trust, Inc.
Claros Mortgage Trust, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor real estat, dengan fokus pada pinjaman hipotek real estat komersial. Sebagai perusahaan investasi real estat (REIT), portofolionya mencakup berbagai aset pinjaman, termasuk pinjaman jembatan dan mezzanine, yang sangat penting bagi klien yang mengelola properti transisi. Perusahaan secara strategis menerbitkan pinjaman ini terhadap properti komersial yang sedang dalam pengembangan ulang atau reposisi, menargetkan pinjaman yang biasanya dijamin oleh properti dalam transisi dengan elemen nilai tambah. Komponen penting dari aktivitas Claros Mortgage Trust melibatkan analisis dan seleksi yang cermat terhadap peluang hipotek komersial yang menunjukkan potensi untuk hasil dan pertumbuhan yang tinggi, selaras dengan strategi investasinya untuk memaksimalkan pengembalian bagi pemegang saham sambil mengelola risiko secara efektif. 		Real Estate 537.62 1.18
347 US PRME / Prime Medicine, Inc. National Commercial Banks 486.75 1.18
348 US MGNX / MacroGenics, Inc.
MacroGenics, Inc. is a biopharmaceutical company headquartered in the United States. It primarily focuses on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and other severe diseases. MacroGenics leverages its proprietary technology platforms, such as DART® and TRIDENT™, to create antibody-based drugs aimed at improving patient outcomes in diseases that currently have limited treatment options. A key project includes the development of margetuximab, an anti-HER2 antibody recently approved by the FDA for breast cancer under the name Margenza. Additionally, MacroGenics has a robust pipeline of candidates in various stages of clinical development targeting a range of oncological and autoimmune diseases. The company demonstrates a strong commitment to advancing science and medicine to meet unmet medical needs. 		Pharmaceutical Preparations 126.41 1.18
349 US CMTL / Comtech Telecommunications Corp.
Comtech Telecommunications Corp., based in the United States, operates predominantly within the global communications sector. The company specializes in providing advanced communication solutions, including command and control technologies, safety and security technologies, and location and messaging services. Comtech's significant projects focus on developing and enhancing satellite ground station technologies and high-performance transmission capabilities. Its services are pivotal for defense, public safety, and commercial applications, enabling reliable and secure communication necessary for operations in remote and challenging environments. The company's strategic direction emphasizes innovation in communications technology to maintain and expand its footprint in these critical areas, supported by ongoing research and development initiatives. 		Radio and Television Broadcasting and Communications Equipment 64.89 1.18
350 US DEFT / DeFi Technologies Inc.
DeFi Technologies Inc., based in Canada, operates within the burgeoning decentralized finance (DeFi) sector, an industry focused on recreating and innovating upon traditional financial services through blockchain technology. The company primarily engages in developmental support, investment, and management of DeFi assets, notably by constructing and nurturing protocols and services that aim to democratize finance by minimizing reliance on central financial intermediaries. Key projects under DeFi Technologies include initiatives around yield farming, liquidity provision, and trading services on decentralized exchanges (DEXs). Additionally, through strategic partnerships and proprietary platforms, the company is at the frontline of offering exposure to DeFi and related assets, enhancing access and engagement for mainstream investors with this disruptive financial technology. 		678.62 1.18
351 US RZLV / Rezolve AI PLC 1.17
352 US DFDV / DeFi Development Corp. Commodity Contracts Brokers and Dealers 260.69 1.17
353 US GAIA / Gaia, Inc.
Gaia, Inc. is a United States-based company focusing primarily on the provision of subscription video streaming services, predominantly delivering original content. Positioned in the entertainment and media sector, Gaia operates from its headquarters in Louisville, Colorado. The company specializes in curated programming that appeals to a niche audience interested in conscious media, emphasizing themes such as spirituality, holistic health, and personal development. Gaia's strategic initiatives revolve around expanding its subscriber base, enhancing content offerings, and boosting engagement through platforms that facilitate user interaction and connectivity. By continuously evolving its content library with unique, self-produced titles and series, Gaia aims to distinguish itself within the competitive landscape of digital media and subscription services. 		Motion Picture, Film, and Video Tape Production 139.22 1.17
354 US SPRO / Spero Therapeutics, Inc.
Spero Therapeutics, Inc., based in the United States, operates within the biopharmaceutical sector, focusing primarily on identifying, developing, and commercializing treatments for multi-drug resistant bacterial infections. A key flagship project of Spero Therapeutics is its innovative product, Tebipenem HBr, which is an orally administered carbapenem antibiotic currently in advanced clinical trials aimed at treating complicated urinary tract infections (cUTI) caused by certain antibiotic-resistant pathogens. This approach marks a significant advancement in addressing critical public health threats posed by antibiotic resistance. Spero's pipeline also includes other novel therapies that target the underlying mechanisms of bacterial resistance, showcasing their commitment to combating infectious diseases through breakthrough scientific innovations. 		Pharmaceutical Preparations 121.08 1.17
355 US ORGN / Origin Materials, Inc.
Origin Materials, Inc., headquartered in the United States, is a pioneering chemical company dedicated to developing innovative carbon-negative materials that can replace petroleum-based products. This enterprise operates primarily within the renewable materials sector, focusing on technology that utilizes non-food biomass as a feedstock to produce intermediate and end-use chemicals. Its key projects include partnerships with major corporations seeking to reduce their carbon footprints using Origin's patented technology platform. Noteworthy collaborations include those with Nestlé and Danone, aimed at producing sustainable plastics for various applications. Origin Materials' business approach combines advancing environmental sustainability with meeting the growing demand for green consumer products, positioning itself strongly in the emerging bio-based economy. 		Industrial Organic Chemicals 75.90 1.17
356 US LTRX / Lantronix, Inc. Computer Communications Equipment 184.96 1.17
357 US PLSE / Pulse Biosciences, Inc.
Pulse Biosciences, Inc. adalah perusahaan yang berbasis di AS yang beroperasi di sektor biomedis, khususnya berfokus pada pengembangan teknologi terapeutik yang memanfaatkan platform Nano-Pulse Stimulation (NPS) miliknya. Perusahaan ini berkantor pusat di Hayward, California, dan mengkhususkan diri dalam merancang dan memasarkan perangkat yang menerapkan pulsa listrik ultra-pendek namun intens ke sel, yang bertujuan untuk menginduksi respons seluler yang bermanfaat dalam aplikasi medis dan estetika. Proyek-proyek utama meliputi pengembangan Sistem CellFX-nya, sebuah perangkat yang dirancang untuk prosedur dermatologis untuk secara tepat menargetkan struktur sel tanpa memengaruhi jaringan non-seluler di sekitarnya. Teknologi ini berpotensi untuk aplikasi di berbagai bidang medis, termasuk onkologi, dermatologi, dan imunoterapi, yang menandakan jalur pertumbuhan inovatif dalam terapi medis berbasis jaringan dan sel. 		Surgical and Medical Instruments and Apparatus 1,014.55 1.16
358 US AGL / agilon health, inc. Miscellaneous Health And Allied Services, Not 495.07 1.16
359 US VERI / Veritone, Inc. Computer Processing and Data Preparation and Processing Services 126.33 1.16
360 US SYRE / Spyre Therapeutics, Inc.
Aeglea BioTherapeutics Inc. adalah perusahaan bioteknologi yang berbasis di AS yang berfokus pada pengembangan terapi berbasis enzim di bidang metabolisme asam amino. 		Pharmaceutical Preparations 1,025.13 1.16
361 US VOR / Vor Biopharma Inc. Biological Products, Except Diagnostic Substances (Biotech) 245.64 1.16
362 US ADVM / Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc., based in the United States, operates within the biotechnology industry, focusing on the development of gene therapy products. The company's primary project revolves around innovative therapies for ocular and rare diseases, using its proprietary vector platforms to address conditions like age-related macular degeneration. Adverum is pioneering in the area of adeno-associated virus (AAV) vectors, a technology that facilitates the delivery of genetic material into cells. Their lead product candidate, ADVM-022, is an investigational gene therapy designed for the treatment of wet age-related macular degeneration, representing a significant advancement in the field and demonstrating their commitment to addressing unmet medical needs through gene therapy solutions. 		Biological Products, Except Diagnostic Substances (Biotech) 74.28 1.16
363 US GPRO / GoPro, Inc.
GoPro, Inc., yang berbasis di Amerika Serikat, beroperasi terutama di sektor elektronik konsumen, berfokus pada desain dan pembuatan kamera aksi, aplikasi seluler, dan perangkat lunak pengeditan video. Terkenal dengan sistem kameranya yang tangguh dan portabel, GoPro telah menciptakan ceruk pasar dalam pengambilan gambar video aksi ekstrem, menarik bagi para penggemar olahraga dan petualang. Lini produk andalannya meliputi seri HERO, yang telah berevolusi melalui beberapa iterasi untuk menyertakan fitur-fitur seperti perekaman video 4K, konektivitas cloud, dan teknologi stabilisasi. GoPro juga telah memperluas portofolio proyeknya untuk mencakup solusi perangkat lunak seperti aplikasi Quik, yang dirancang untuk memfasilitasi pengeditan dan berbagi video, sehingga memperkuat ekosistemnya dan meningkatkan keterlibatan pengguna. 		Photographic Equipment and Supplies 236.97 1.16
364 US INNV / InnovAge Holding Corp. Pharmaceutical Preparations 511.95 1.16
365 US TTSH / Tile Shop Holdings, Inc. Home Furniture, Furnishings, And Equipment Stores 278.08 1.16
366 US EDIT / Editas Medicine, Inc.
Editas Medicine, Inc., based in the United States, operates within the biotechnology sector and is notable for its pioneering efforts in gene editing technology. Specializing in the CRISPR/Cas9 and CRISPR/Cas12 systems, the company focuses on developing transformative gene-editing therapies to treat a diverse range of diseases with unmet medical needs. Key projects include a leading development program targeting Leber Congenital Amaurosis type 10 (LCA10), a severe genetic eye disorder, endeavoring to correct this mutation-driven ailment at the DNA level. Additionally, Editas Medicine sustains active research in exploring treatment options for other genetic conditions, including sickle cell disease and beta-thalassemia, signifying its strategic commitment to medical innovation and genetic disease treatment. 		Biological Products, Except Diagnostic Substances (Biotech) 240.76 1.16
367 US PROK / ProKidney Corp. Biological Products, Except Diagnostic Substances (Biotech) 300.86 1.15
368 US NB / NioCorp Developments Ltd.
NioCorp Developments Ltd. is a mining corporation headquartered in Centennial, Colorado, USA. It primarily focuses on extracting and developing critical minerals necessary for various advanced industries, such as green energy and technology sectors. Its flagship project is the Elk Creek Superalloy Materials Project located in Nebraska. This project is significant due to its rich deposits of niobium, scandium, and titanium, which are essential for producing superalloys and other high-performance materials. As of the most recent updates, NioCorp is working towards securing financing and obtaining necessary permits to advance the project towards the construction and operational phases, positioning itself strategically within the critical minerals market essential for modern technologies. 		Metal Mining 201.26 1.15
369 US MAPS / WM Technology, Inc. Prepackaged Software 125.99 1.15
370 US EHTH / eHealth, Inc.
EHealth, Inc., based in the United States, primarily operates within the health insurance sector. This company has carved out a niche in the digital healthcare space by providing a comprehensive online platform for insurance information and comparison. Its primary product is an Internet-based portal where consumers can compare health insurance plans from multiple providers to find the coverage that best suits their needs. EHealth, Inc. also offers a range of tools and services, such as enrollment in Medicare, individual, and family insurance plans directly through their platform. Their initiatives aim to simplify the insurance selection process by leveraging technology to enhance accessibility and consumer choice in health insurance markets. 		Insurance Agents, Brokers, and Service 124.20 1.15
371 US ATAI / Atai Life Sciences N.V.
Atai Life Sciences N.V., headquartered in the Netherlands, operates primarily within the biotechnology sector, specializing in the development of treatments for mental health disorders. The company employs a unique approach by focusing on psychedelic and non-psychedelic compounds to innovate solutions for conditions that are typically resistant to conventional therapies. A key pillar of Atai Life Sciences' work revolves around leveraging advanced scientific research to demystify and effectively target the underlying biological mechanisms of mental illnesses. Central to their mission, Atai invests in a diverse portfolio of therapeutic projects that explore novel drug development pathways, including the exploration of psilocybin and other compounds, to address significant unmet medical needs in the psychiatric space, aiming at revolutionizing the mental health treatment landscape. 		Pharmaceutical Preparations 968.90 1.15
372 US ETHZ / ETHZilla Corporation
180 Life Sciences Corp. adalah perusahaan bioteknologi tahap klinis yang berfokus pada pengembangan obat-obatan baru yang memenuhi kebutuhan yang belum terpenuhi dalam penyakit peradangan, fibrosis, dan nyeri dengan memanfaatkan keahlian gabungan dari tokoh-tokoh terkemuka dalam terapi dari Universitas Oxford, Universitas Ibrani, dan Universitas Stanford. 		Pharmaceutical Preparations 14.01 1.15
373 US ARBE / Arbe Robotics Ltd. Blank Check 145.29 1.14
374 US GTE / Gran Tierra Energy Inc.
Gran Tierra Energy Inc., headquartered in Calgary, Canada, operates as an international oil and gas exploration and production company, primarily focused on opportunities in South America. With a strong presence in Colombia, where the majority of its operations and key assets are located, the company is involved in the development of both conventional and unconventional reservoirs. Gran Tierra holds a strategic portfolio of assets that includes significant acreage in the Putumayo and Middle Magdalena Valleys, which are known for their substantial hydrocarbon potential. The company's approach combines a commitment to operational excellence and sustainable practices, aiming to leverage technological expertise and in-depth regional knowledge to optimize asset performance and production efficiency. 		Crude Petroleum and Natural Gas 138.51 1.14
375 US AXTI / AXT, Inc.
AXT, Inc. is a U.S.-based company, headquartered in Fremont, California, that specializes in the production of semiconductor substrates. The company operates principally within the semiconductor industry, focusing on the manufacture of high-performance, compound semiconductor substrates which include materials such as gallium arsenide, indium phosphide, and germanium. These materials are vital for applications in high-speed communication, wireless, and optoelectronic products. Key projects and activities routinely involve enhancing material development to aid advancements in electronic and optoelectronic device markets. The company maintains a global presence with significant manufacturing capabilities in China, serving both international and domestic markets, thus underpinning its strategic position in the semiconductor substrate sector. 		Semiconductors and Related Devices 135.89 1.14
376 US KOPN / Kopin Corporation
Kopin Corporation, based in the United States, is a prominent player in the microdisplay technology sector, focusing primarily on manufacturing high-resolution screens for a variety of military, consumer, and industrial applications. The company's diverse product lineup includes ultra-small displays for use in virtual and augmented reality (VR and AR), thermal weapon sights, and pilot helmets. Noteworthy projects include innovative partnerships with defense departments for enhancing the capabilities of military equipment through improved head-mounted displays. Kopin Corporation is also actively involved in evolving consumer electronics through the development of lightweight, power-efficient solutions for VR and AR glasses, positioning itself as a key contributor to the advancement of next-generation wearable technologies. 		Semiconductors and Related Devices 331.97 1.14
377 US PL / Planet Labs PBC 1,987.29 1.14
378 US EVTL / Vertical Aerospace Ltd. Aircraft 387.82 1.13
379 US RAVE / Rave Restaurant Group, Inc. Groceries And Related Products 48.60 1.13
380 US DLNG / Dynagas LNG Partners LP - Limited Partnership
Dynagas LNG Partners LP, based in Greece, operates within the energy sector, primarily focusing on the transportation of liquefied natural gas (LNG) through its fleet of LNG carriers. This limited partnership specializes in the ownership and management of LNG vessels engaged in multi-year charters, aligning with major energy companies and users. Its fleet consists of specifically designed LNG carriers that cater to different geographical, technical, and contractual needs. Key projects typically involve long-term charters which provide steady and predictable revenue streams, crucial for maintaining and expanding its operational capabilities. Dynagas has positioned itself strategically within the LNG transportation industry, optimizing its fleet utilization and financial performance through long-standing industry relationships and technical expertise in marine logistics. 		Water Transportation 138.44 1.13
381 US SIFY / Sify Technologies Limited - Depositary Receipt (Common Stock)
Sify Technologies Limited is an information and communications technology company based in India. It operates primarily in the provision of integrated ICT solutions and services, such as managed network, data center solutions, and software services across various industries. A key aspect of Sify's portfolio includes enhancing enterprise connectivity through offerings like internet, network, and cloud solutions. Additionally, the company has made significant investments in expanding its data center capabilities, aiming to establish a more robust infrastructure platform that supports a wide range of business operations and e-commerce solutions. Sify Technologies also drives projects that facilitate digital transformation for its clients, thereby reinforcing its position in the rapidly evolving ICT sector. 		Computer Programming, Data Processing, And Other Computer Related Services 1.13
382 US SPWH / Sportsman's Warehouse Holdings, Inc.
Sportsman's Warehouse Holdings, Inc., headquartered in the United States, operates primarily in the retail industry focused on outdoor sporting goods. Specializing in a wide array of products, the company caters to outdoor enthusiasts, offering equipment, apparel, and accessories for hunting, fishing, camping, and shooting sports. Sportsman's Warehouse has grown significantly since its inception, leveraging both brick-and-mortar stores and an online platform to reach a broad consumer base. The company’s strategic initiatives often include expanding their physical store footprint and enhancing their e-commerce capabilities to better serve their customer base and compete effectively in the outdoor sporting goods market. Through these efforts, Sportsman's Warehouse continues to strengthen its market position by providing high-quality products and expertise in the outdoor sports industry. 		Miscellaneous Shopping Goods Stores 130.03 1.13
383 US HIVE / HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd., based in Canada, operates primarily within the cryptocurrency mining sector. It focuses on the mining of digital currencies like Bitcoin and Ethereum, utilizing green energy to power its operations, thereby addressing environmental concerns associated with crypto-mining. By harnessing renewable energy sources, HIVE aims to achieve a lower carbon footprint compared to conventional mining practices. In addition to its core mining activities, the company is also involved in the development of data center infrastructure essential for its mining operations. This strategic approach not only enhances its operational efficiency but also bolsters its capacity to scale in a rapidly evolving digital currency landscape. 		Finance Services 542.48 1.12
384 US AEHR / Aehr Test Systems, Inc.
Aehr Test Systems adalah penyedia terkemuka peralatan pengujian semikonduktor yang berbasis di Amerika Serikat, dengan kantor pusat di Fremont, California. Beroperasi terutama di industri semikonduktor, perusahaan ini berfokus pada pengembangan dan pembuatan sistem canggih untuk memastikan keandalan perangkat semikonduktor baik selama fase produksi maupun pasca-produksi. Produk-produk utama meliputi perlengkapan uji, burn-in, dan sistem pengujian yang sangat penting untuk menilai fungsionalitas dan daya tahan sirkuit terpadu dan wafer silikon. Proyek yang menonjol adalah sistem FOX-XP-nya, yang mendukung produksi volume tinggi dan pengujian tingkat kegagalan awal chip logika dan memori yang kompleks. Inovasi Aehr terutama melayani pasar otomotif, elektronik konsumen, dan penyimpanan data, membantu produsen meningkatkan kualitas dan keandalan produk elektronik canggih. 		Instruments for Measuring and Testing of Electricity and Electrical Signals 764.54 1.12
385 US BRY / Berry Corporation
Berry Corporation, yang berbasis di Amerika Serikat, terutama beroperasi di sektor energi, dengan fokus pada eksplorasi dan produksi minyak dan gas alam. Terutama aktif di California, perusahaan ini merupakan salah satu produsen minyak dan gas terbesar di wilayah tersebut, dengan proyek-proyek signifikan yang berpusat pada peningkatan efisiensi ekstraksi dan produksi sambil mematuhi standar lingkungan dan keselamatan yang ketat. Berry Corporation memanfaatkan teknik pemulihan canggih dan manajemen aset strategis untuk mengoptimalkan basis sumber daya yang substansial di reservoir minyak konvensional, bertujuan untuk memasok energi secara berkelanjutan sambil tetap berkomitmen pada pengelolaan lingkungan yang bertanggung jawab. Fokus strategisnya adalah mempertahankan efektivitas biaya dan memaksimalkan nilai ladang minyaknya yang sudah matang, memastikan kinerja yang stabil di pasar energi yang fluktuatif. 		Crude Petroleum and Natural Gas 248.31 1.12
386 US HONE / HarborOne Bancorp, Inc.
HarborOne Bancorp, Inc., based in the United States, primarily operates in the banking industry, offering a broad spectrum of financial services. As a prominent entity in the Northeastern U.S., particularly Massachusetts, the company focuses on providing retail and commercial banking products. Essential services include checking and savings accounts, mortgage lending, auto loans, and business banking solutions. Additionally, through its subsidiary, HarborOne Mortgage, LLC, it significantly contributes to the residential lending market in its operational regions. A key project for HarborOne has been its strategic transformation from a credit union to a public bank in 2016, aimed at expanding its business capabilities and market reach. This shift underscores HarborOne's commitment to growth and innovation within the competitive financial services sector. 		State Commercial Banks 517.43 1.12
387 US INVZ / Innoviz Technologies Ltd. Motor Vehicle Parts and Accessories 319.23 1.12
388 US ACCO / ACCO Brands Corporation
ACCO Brands Corporation, based in the United States, is a leading player in the office products industry globally. The company designs, manufactures, and markets a wide range of traditional and computer-related office products and supplies, including binders, staplers, shredders, and whiteboards under well-known brands such as Mead, Swingline, and Kensington. Operational since 1903, ACCO Brands has focused on expanding its product portfolio and market reach through strategic acquisitions, notably the purchase of General Binding Corporation in 2005 and MeadWestvaco's Consumer & Office Products division in 2012. These acquisitions have enabled ACCO to bolster its presence in key markets and enhance its product lineup, reinforcing its position as a dominant supplier to the office and school supplies sector. 		Blankbooks, Looseleaf Binders, And Bookbinding 370.98 1.11
389 US VANI / Vivani Medical, Inc. Electromedical and Electrotherapeutic Apparatus 77.61 1.11
390 US PETS / PetMed Express, Inc.
PetMed Express, Inc., based in the United States, operates principally in the healthcare sector, specifically focusing on the pet pharmacy industry. Founded in 1996 and headquartered in Florida, the company has established itself as a leading online pet pharmacy, providing prescription and non-prescription pet medications, along with health and nutritional supplements. PetMed Express markets these products directly to the consumer through its website and via its toll-free number. A key project for the company has been enhancing its e-commerce platform to improve user experience and expand its product range. This strategy aims to address the growing demand for convenient and affordable pet care solutions, leveraging technology to streamline operations and engage effectively with a broad customer base. 		Drug Stores and Proprietary Stores 1.11
391 US KMDA / Kamada Ltd. Pharmaceutical Preparations 405.11 1.11
392 US NUVB / Nuvation Bio Inc. Pharmaceutical Preparations 1,329.58 1.11
393 US TACT / TransAct Technologies Incorporated Computer Peripheral Equipment, Not Elsewhere Classified 45.53 1.11
394 US SMHI / SEACOR Marine Holdings Inc.
SEACOR Marine Holdings Inc., based in the United States, operates in the global marine and support transportation services arena, primarily serving the offshore oil and gas exploration and production industry. As a significant player in its sector, SEACOR Marine specializes in providing a diverse range of marine assets for offshore oil and gas, government, and wind energy projects. The company’s fleet, among the most modern in the industry, includes support vessels that deliver cargo and personnel, towing rigs and servicing offshore installations, and handling anchors for drilling rigs and laying cables. With a focus on innovation and safety, SEACOR Marine continuously explores technological advancements to enhance its operational efficiency and environmental compliance, positioning itself as a leader in maritime services for various high-demand sectors. 		Deep Sea Foreign Transportation of Freight 174.00 1.11
395 US BITF / Bitfarms Ltd.
Bitfarms Ltd. is a publicly traded cryptocurrency mining company primarily involved in the production of Bitcoin. Based in Toronto, Canada, the company constitutes a significant presence in the blockchain sector by operating one of the largest cryptocurrency mining operations in North America. Bitfarms' key projects focus on expanding its mining capabilities and enhancing energy efficiency across its data centers that are strategically located to utilize cost-effective, predominantly hydroelectric power. This commitment not only to scale but also to sustainability, seeks to position Bitfarms favorably within an increasingly competitive and environmentally concerned market. The firm continually invests in the latest mining technology and infrastructure to ensure high operational efficiency and profitability in the volatile cryptocurrency landscape. 		Finance Services 716.45 1.11
396 US SENS / Senseonics Holdings, Inc.
Senseonics Holdings, Inc., based in the United States, operates within the healthcare sector, specifically focusing on the development and commercialization of glucose monitoring systems for people with diabetes. A prominent player in medical technology, the company's main product, the Eversense® Continuous Glucose Monitoring (CGM) system, distinguishes itself with its long-term implantable device. This system allows for continual glucose monitoring for up to 90 and 180 days, offering significant advantages in terms of convenience and efficiency compared to traditional CGM systems. The innovative nature of Senseonics' solutions aligns with their commitment to enhancing diabetic care management through advanced sensor technology and data integration capabilities. 		Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products 369.49 1.11
397 US SKIN / The Beauty Health Company
The Beauty Health Company, yang berbasis di Amerika Serikat, beroperasi di sektor kesehatan dan kecantikan, terutama berfokus pada produk dan layanan perawatan kulit estetika. Perusahaan ini telah mendapatkan popularitas melalui merek andalannya, HydraFacial, perawatan kulit non-invasif yang menggabungkan pembersihan, pengelupasan, ekstraksi, hidrasi, dan perlindungan antioksidan. Teknologi eksklusif ini melayani pasar profesional dan konsumen, menekankan solusi perawatan kulit yang dapat disesuaikan. The Beauty Health Company secara aktif mengejar inovasi dalam kesehatan dermatologis, terus memperluas penawaran produknya untuk mencakup berbagai perawatan dan serum peningkat kulit yang memenuhi beragam kebutuhan pelanggan di seluruh dunia. Inisiatif strategis perusahaan bertujuan untuk lebih menembus pasar estetika medis, menyoroti komitmen untuk memberikan solusi yang efektif secara klinis yang menumbuhkan kepercayaan dan loyalitas konsumen. 		Surgical and Medical Instruments and Apparatus 259.87 1.11
398 US ACHV / Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., based in the United States, operates within the biopharmaceutical industry focused on developing and commercializing novel treatments for addiction and related disorders. One of its key projects involves the development of cytisinicline, a plant-based alkaloid with a high-binding affinity to the nicotinic acetylcholine receptor, aimed at aiding smoking cessation. This compound represents a significant breakthrough in addressing nicotine addiction, offering a potential alternative to traditional therapies with a differing mechanism of action. Life Sciences is advancing its clinical development, actively engaging in multiple phase 3 trials to further evaluate the efficacy and safety of cytisinicline for broad therapeutic use. 		In Vitro and In Vivo Diagnostic Substances 140.61 1.10
399 US NKTX / Nkarta, Inc. Pharmaceutical Preparations 160.52 1.10
400 US DYN / Dyne Therapeutics, Inc. Electric Services 1,625.90 1.10
401 US SHOT / Safety Shot, Inc. Perfumes, Cosmetics, and Other Toilet Preparations 39.01 1.10
402 US INVE / Identiv, Inc.
Identiv, Inc. adalah perusahaan teknologi yang berbasis di Amerika Serikat yang beroperasi terutama di sektor keamanan dan manajemen identitas. Didirikan pada tahun 1990, fokus Identiv adalah mengembangkan dan menyediakan solusi keamanan yang terukur untuk perusahaan, lembaga pemerintah, dan konsumen. Produk intinya meliputi sistem kontrol akses fisik, layanan manajemen identitas, dan aplikasi yang mendukung RFID. Perusahaan ini semakin memanfaatkan keahliannya ke area-area penting seperti keamanan pemerintah federal dan solusi berbasis IoT, yang secara konsisten bertujuan untuk mengatasi tantangan keamanan siber dan identifikasi modern. Proyek-proyek utama telah berkembang ke area seperti otentikasi yang aman dan teknologi kredensial tertanam, yang relevan di lingkungan perusahaan, perawatan kesehatan, pendidikan, dan bahkan berpotensi produk konsumen. Upaya strategis Identiv mencerminkan komitmennya terhadap inovasi dan keamanan di era digital, menjadikannya terdepan di industrinya. 		Computer Peripheral Equipment, Not Elsewhere Classified 91.59 1.09
403 US VWAV / VisionWave Holdings, Inc. 25.89 1.09
404 US FNKO / Funko, Inc.
Funko, Inc., based in the United States, is a prominent player in the collectibles industry, specializing in the design, sourcing, and distribution of licensed pop culture products. Established in 1998, Funko is renowned for its broad array of licensed vinyl figurines and bobbleheads, which it markets under the popular Pop! brand. The company collaborates with numerous major entertainment companies, covering a wide range of content from movies, TV shows, and video games to sports and music. The diversification and appeal of its product lines have positioned Funko as a cultural and commercial leader in the novelty and collectibles market sector. Further strengthening its market position, Funko has expanded into apparel, accessories, and digital experiences, including the development of immersive virtual products and interactive gaming initiatives, which enhance its traditional revenue streams and engagement with a global consumer base. 		Games, Toys, and Children's Vehicles, Except Dolls and Bicycles 178.31 1.09
405 US INBX / Inhibrx Biosciences, Inc. Biological Products, Except Diagnostic Substances (Biotech) 407.93 1.09
406 US RNA / Avidity Biosciences, Inc. Pharmaceutical Preparations 6,082.98 1.09